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Abstract
The development of an artificial bypass graft for the treatment of peripheral vascular 
disease would overcome the limitations of using autologous veins. An ideal graft 
would be a tubular structure made from an elastomeric polymer. Layers of autologous 
cells would then be cultured on the inside of the tube in order to render the graft non- 
thrombogenic. The aim of this work was to modify the surface of a polyurethane by 
covalently attaching recombinant extracellular matrix proteins in order to gain a 
degree of control over the behaviour of smooth muscle cells.
A chemical modification protocol was used to attach the proteins to the polyurethane 
via a layer of dextran. The proteins used were an RGD-containing fragment of 
fibrillin-1 and full length tropoelastin. These are proteins found in the artery wall. 
Protein immobilisation was verified using Enzyme Linked Immunosorbent Assays. 
RGD-dependence of cell attachment was investigated by incubating the cells with a 
soluble RGD-containing peptide prior to seeding. The contribution of integrins a vp3 
and (X5P1 to the attachment of the cells was determined using blocking antibodies. Cell 
proliferation and spreading were quantified. Gene expression and protein production 
were investigated using RT-PCR, immunostaining and Western blotting.
Attachment to the fibrillin-modified surface was found to be highly RGD-dependent 
and both integrins investigated were found to be involved. The integrin avP3 was also 
found to be involved in cell attachment to the tropoelastin surface. The level of 
spreading was higher on the fibrillin surface compared to the tropoelastin or the plain 
polyurethane. Immunostaining of integrins showed few classical focal adhesions and 
evidence of more fibrillar adhesions. Various extracellular matrix proteins were 
produced by the cells on both modified surfaces but only in low amounts.
The results of this work show that the modification protocol is an effective way to 
attach proteins to polymer surfaces whilst retaining their cell binding properties. The 
proteins investigated here initiated varying cellular responses.
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Chapter 1 -  Introduction
1.1 -  Literature Review
1.1.1 - Peripheral Vascular Disease
Peripheral vascular disease is characterised by a build up of fatty deposits in the 
lining of the arteries of the limbs. As the plaques increase in size they disrupt the 
endothelial cell layer. This causes a phenotypic modulation of the underlying smooth 
muscle cells (SMCs) allowing them to proliferate and migrate into the intima. They 
also begin to secrete extracellular matrix proteins further decreasing the diameter of 
the blood vessel.1'4
The plaques increase in size over time reducing blood flow, and therefore oxygen 
delivery, to the limbs. At first this causes discolouration of the hand or foot (Figure 
1). As the blood flow decreases further there will be intermittent claudication then 
pain at rest. In the absence of intervention eventually gangrene and tissue necrosis 
will develop resulting in the need for amputation.
9
Figure 1 — An ischaemic foot. Image provided by Dr Thien How, Clinical Engineering,
University of Liverpool
Diabetes is a major risk factor for peripheral vascular disease. Reduced blood flow to 
the extremities along with diabetic nerve damage causes a high incidence of non­
healing foot ulcers in people with the condition. These can also result in the need for 
amputation. One UK study showed that between 1999 and 2000 there were 
approximately 2.61 amputations per 1,000 people with diabetes in the local 
population.5
A number of diagnostic techniques are used to identify peripheral vascular disease, 
most commonly measurement of the ankle brachial pressure index followed by 
angiography (Figure 2).
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Figure 2 -  An angiogram showing occlusion of the left femoral artery (arrow). Image provided 
by Dr Thien How, Clinical Engineering, University of Liverpool
Treatment of the condition initially includes lifestyle changes i.e. cessation of 
smoking, lowering LDL cholesterol in the diet, lowering blood pressure and 
controlling diabetes. Cholesterol reducing drugs may be used. Angioplasty can be 
used to expand larger vessels; sometimes a stent is also deployed. Bypass grafting 
uses a graft that is sutured above and below the blockage to allow the blood flow to
be resumed to the lower limb.
1.1.2 - Treatment by Bypass Grafting
1.1.2.1 -  Autologous Graft
The most commonly used blood vessels used as autologous bypass grafts are the 
saphenous vein and the internal mammary artery. These have a high patency and are 
the preferred choice of graft at present. However, in some cases these vessels are not 
suitable or are unavailable. The vessel may be diseased or may not be the right size. It 
is also possible that the vessel has been taken for a previous graft. In addition, vein 
grafts have thin walls that may not be able to withstand the higher blood pressure 
found in arteries.6
1.1.2.2 -  Xenogenic/Allogenic Graft
The availability of xenogenic grafts (from a different species) or allogenic grafts 
(from a donor of the same species) is not a problem. Umbilical veins that have been 
glutaraldehyde treated to reduce immunogenicity have been used as an alternative to 
autologous vessels.7,8 The patency of these grafts is lower than for autologous grafts 
but is an adequate alternative in situations where life expectancy is low. After 
prolonged periods of implantation the graft is susceptible to aneurysm. Other 
problems include the incomplete removal of immunogenicity by the cross-linking and 
the presence of residual glutaraldehyde in the tissue.6,9 Acellularised tissue has also 
been investigated. Methods employing a variety of detergents and enzymes are used
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to remove the cellular component from an allograft or xenograft whilst leaving the 
extracellular matrix intact.10 The thrombogenicity of these grafts can however be an 
issue.
1.1.2.3 -  Synthetic Graft
Another option when an autologous graft is unavailable is a synthetic graft. These 
consist of a polymer tube, usually poly(ethylene terephthalate) (Dacron) or expanded 
poly(tetrafluoroethylene) (ePTFE).11 16 However, these grafts have low patency for 
small diameter vessels such as those of the lower limbs. The surface of the polymers 
is thrombogenic and so blood clots are common. Also, they are rigid and so cause 
compliance mis-match at the anastomoses. This causes turbulent blood flow and this 
is thought to be a contributing factor to re-stenosis of the graft. The use of a more 
compliant polymer such as polyurethane could overcome this problem but these 
grafts are prone to aneurysm and have been shown to be even more thrombogenic 
than ePTFE grafts.17 A number of methods have been investigated in order to reduce 
the thrombogenicity of synthetic grafts. One of these methods is to implant the graft 
into the peritoneal cavity of the patient in order to obtain a fibrous capsule that would 
reduce thrombus formation when the graft was used.18,19 In a different approach 
heparin has been attached to the internal surface of a synthetic graft before 
implantation.20'23 The occurrence of spontaneous endothelialisation of an implanted 
graft has also been investigated.24 The endothelial layer would mimic the native 
intimal surface and therefore prevent thrombus formation. In animal studies complete
13
endothelialisation of the implanted grafts occurred. In contrast, in-growth into grafts 
implanted into human did not exceed 10mm even after extensive periods of time.
1.1.2.4 - Cell-Seeded Graft
In the absence of spontaneous endothelialisation, seeding endothelial cells onto the 
internal surface of the graft prior to implantation has been investigated as a way to 
form an endothelial layer. A number of variations on this idea have been explored. 
Non-degradable polymers such as Dacron, ePTFE and polyurethane have been seeded 
with endothelial cells and their retention on the surface investigated under flow 
conditions either in vitro or in vivo.15’16,26 Cell-seeding was shown to improve 
patency of the implanted grafts compared to non-seeded controls. Biodegradable 
polymers such as poly(lactic acid) have also been tried. Whilst cell adhesion to these 
surfaces did occur it would not be sufficient for a high level of retention in vivo. 27 9
In order to achieve adequate cell adhesion to polymer surfaces so that the cells are 
retained under physiological conditions it is necessary to modify the surface in some 
way. One strategy is modification of the surface topography. Both nanometer and 
micrometer scale roughness have been shown to increase cell adhesion, proliferation 
and migration.30'32 It is unlikely however that this modification alone would be 
adequate to retain the cells on implantation into the body.
14
Cell membranes consist of a phospholipid bilayer. This means that the cell surface is 
polar and therefore moderately hydrophilic. It follows that cells will bind more easily 
to hydrophilic surfaces. To this end research has been carried out to increase the 
wettability of polymer surfaces. This can be achieved by treating the surface to 
change its chemistry or by attaching hydrophilic molecules.33'38 Again it is doubtful 
that the cell adhesion would be increased to the necessary level for in vivo conditions.
In 1984 the tri-peptide arginine-glycine-aspartic acid (RGD) was identified as the 
minimum cell adhesion motif recognised by integrins.39 This sequence is found in 
fibronectin and a number of other proteins. Other short peptides have now also been 
identified as increasing cell attachment. These include REDV (fibronectin), YIGSR 
(laminin) and IKVAV (laminin). The covalent attachment of these peptides has since 
been shown by many groups to dramatically improve cell adhesion to surfaces (see 
section 1.1.3.2.2).
In their native environment cells are surrounded by extracellular matrix and basement 
membrane proteins. A great deal of research has concentrated on coating surfaces 
with these proteins in order to increase cell adhesion. Proteins such as fibronectin and 
laminin have been shown to successfully improve adhesion, proliferation and 
spreading on surfaces (see section 1.1.3.3.2). The adsorption of these proteins 
however is not adequate to promote the necessary strength of cell attachment as the 
protein has to withstand the contractile forces applied by the cells.40 It has also been 
shown that the physical state of the protein i.e. adsorbed as opposed to immobilised, 
has an effect on the cytoskeletal organisation of the cells.41
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1.1.3 -  Polymer Surface Modification
1.1.3.1 -  Surface Functionalisation
The majority of polymers that have been investigated as potential vascular graft 
materials have no functional groups available on their surface, PTFE for example. In 
order to attach cell adhesion molecules to these polymers it is necessary to first 
functionalise the surface. A commonly used method for introducing functional groups 
to surfaces is plasma treatment whereby a plasma is formed by applying a 
radiofrequency discharge to a gas filled chamber. The gas is ionised producing 
species with an energy high enough to break covalent bonds. If the polymer to be 
modified is placed in the plasma chamber its surface is bombarded by these species, 
breaking bonds to form functional groups.33,42,43 By placing the polymer immediately 
into a protein solution the groups can react with carboxyl or amino functionalities 
directly therefore immobilising the protein on the surface.44-48 Another method is to 
graft glutaraldehyde to the functionalities formed by the plasma treatment. This 
produces carboxyl groups on the surface that can then be used for binding cell 
adhesion molecules.49 Alternatively acrylic or methacrylic acid can be grafted to the 
surface groups again producing carboxyl groups.21,50-53
Ozone can be used to oxidise polymer surfaces resulting in the formation of reactive 
peroxide groups. These groups can then react directly with a protein in solution or be
. . 54 55
used to graft acrylic acid to the surface in order to provide carboxyl moieties. ’
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In the case of some polymers it is possible to break bonds on the surface by 
hydrolysis. Treatment with concentrated sodium hydroxide has been used to form 
carboxyl groups on the surface of various polymers including poly(methyl
56 62methacrylate), poly(glycolic acid) and poly(ethyleneterephthalate). "
Aminolysis is another method that can be used to functionalise polyester based 
materials such as poly(lactide) or poly(caprolactone). An amine-containing 
compound is added to the polymer surface where it reacts at the ester bond to form an 
amide linkage. By using a diamine, 1,6-hexanediamine for example, as the reactant
63 67the surface becomes amine functionalised. '
Blending the polymer to be used with a functionalised polymer prior to scaffold 
formation can, in some instances, produce reactive groups on the surface but also 
maintain some of the physical properties of the polymer. In one study the carboxy 
terminal of poly(L-lactide) was functionalised with a diamine. This PLLA-NH2 was 
then blended with non-modified PLLA before a porous scaffold was synthesised.68 
This method is only capable of providing a small number of reactive groups however.
In a similar manner, a functionalised polymer can be blended into the surface layer of 
another polymer. The surface is swelled using a solvent/non-solvent mixture allowing 
the functionalised polymer to diffuse into it. An excess of non-solvent then traps this 
polymer in the surface leaving active groups available. Polymers including 
poly(lysine) and polyethylene glycol) have been physically trapped in surface layers 
using this method.69'72
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1.1.3.2 -  Cell Adhesion Peptides
1.1.3.2.1 - Methods of Attachment
Carbodiimides are commonly used reagents that facilitate the reaction of an amine 
group with a carboxylic acid. They react with the acid group thus activating it and 
driving the reaction with the amine (Figure 3). The original carbodiimide used for 
these reactions was N,N'-dicyclohexylcarbodiimide (DCC). However, this is an 
allergen and the by-product of the reaction is insoluble. More commonly used now is 
the water soluble l-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride 
(EDC).
Figure 3 -  Reaction scheme for the immobilisation of a peptide onto a carboxylated surface using
a carbodiimide
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Aminophase glass has been used to demonstrate the feasibility of using this reaction 
to couple peptides to a surface. For this, the EDC is used to activate the C-terminal of 
the peptide for reaction with the amine groups on the surface.73'76 The carbodiimide 
can also be used to activate surface carboxyl groups for reaction with the N-terminal 
of the peptide. This method was used to attach adhesion peptides to oxidised 
polyethylene terephthalate),77 carboxylated polyurethane78’79 and poly(acrylic acid) 
grafted to polystyrene.52
N-hydroxy succinimide (NHS) is often used alongside carbodiimides to increase the 
product yield. When added to the reaction mixture, the NHS replaces the O-acylurea
group formed by the reaction of the carbodiimide activated carboxyl with the amino
80group. This method has been used to attach cell adhesion peptides to silk films, 
PEG-tethered polypropylene fumarate),81 polyethylene oxide),82 
poly(caprolactone) and dextran-tethered polyurethane.
Tresyl chloride (2,2,2-trifluoroethanesulphonyl chloride) is a coupling reagent that 
can be used to activate surface hydroxyl groups for reaction with the amino groups of 
peptides. This method has been used to immobilise various peptides to 
poly(tetrafluoroethylene-co-hexafluoropropylene)84'86 and hydroxylated
87poly(ethyleneterephthalate) and poly(tetrafluoroethylene).
In a different approach cell adhesion peptides can be derivatised with a phenyl azido 
moiety to enable photochemical immobilisation onto polymer surfaces. The 
derivatised peptide is adsorbed on to the surface before UV irradiation is used to
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chemically bond it (Figure 4). This method has been used to graft RGD-containing 
peptides to polyurethane-PEG, poly(caprolactone)-PEG, poly(vinyl alcohol) and 
chitosan films.30,88'92
N. + N2
' '
H H2
N--- C
I „
Figure 4 -  Reaction scheme for the immobilisation of an azido-derivatised peptide onto a
polymer surface
1.1.3.2.2 - Cellular Responses
The cellular responses to surfaces immobilised with cell adhesion peptides have been 
investigated extensively. The peptides have been shown to have an effect on cell 
adhesion,49'52,63,74'78'80'83’87’90'91'93'100 spreading,78'79,101'107 proliferation,74'89'91,108'110
differentiation49'68 and extracellular matrix production.74'80'108 However, there are a
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number of factors that affect cell behaviour on the surfaces. It has been shown that 
the amino acids that make up the peptide are very specific. For example, there is a 
significant difference in cell adhesion to RGD-modified surfaces and RGE-modified 
surfaces.74,79,111’112 Replacing the aspartic acid residue with the structurally similar 
glutamic acid significantly reduced the adhesion and spreading of cells cultured on 
the modified surface. It was also observed that cells cultured on the RGE surfaces 
secreted considerably more extracellular matrix then those on the RGD surfaces.73 In 
another study cell adhesion to the peptides YIGSE and YGGGR was found to be 
significantly lower than to the YIGSR motif found in laminin.113
By changing the sequence of the amino acids cell behaviour is altered extensively. 
RDG-modified surfaces showed reduced cell spreading and proliferation compared to 
RGD surfaces.105
The amino acid residues either side of the cell-adhesion motif also have an effect on 
cell behaviour. In fibronectin the amino acid directly after the RGD is a serine 
whereas in vitronectin it is a valine. A comparison of GRGDSY-modified surfaces 
with GRGDVY-modified surfaces showed greater cell attachment to the 
GRGDVY.78,79 This was attributed to differing affinities of the peptides for the cell- 
surface receptors.
If the cell adhesion peptide is free in solution rather than immobilised on to a surface 
it will bind to the receptors of the cells and block them. This will prevent the cells 
from adhering to the surface. The level of inhibition of cell adhesion can therefore be
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used as an indicator of the binding potential of the cells to the peptide. This principle 
has been used to investigate the effect of altering the conformation of one of the 
amino acids in the RGD motif. Substituting L-Arg for D-Arg made very little 
difference to the cell attachment. However, when the same substitution was carried 
out on the Asp residue, the peptide became inactive.114 These results show that the 
conformation of the peptide alters its affinity for cell surface receptors.
The density of the cell adhesion peptides on a surface has also been shown to affect 
the behaviour of cells. The minimum amount of RGD needed on a surface to promote 
the formation of focal adhesions has been calculated." Cells were fully spread on 
surfaces with a peptide density of lfmol/cm2 and at 10fmol/cm2 they were found to 
have formed focal contacts and well organised stress fibres. These results show that 
only a very small amount of RGD peptide is needed to promote integrin-mediated 
cell adhesion. Another study used well-defined nano-patterned surfaces to show that 
cell adhesion to RGD was decreased when the peptide-covered nanodots were over 
73nm apart from each other. Each nanodot was capable of binding one integrin and so 
the decrease in cell adhesion was attributed to the fact that the integrins were 
prevented from forming clusters.115 Cell adhesion can be enhanced by increasing the 
concentration of peptide on a surface.52’88,90,116 Peptide density also effects cell 
migration. The presence of low concentrations of peptide increases migration 
compared to non-adhesive control surfaces. However, at high peptide concentrations 
migration is suppressed.74 For a cell to migrate it needs to form focal adhesions on the 
surface. The cell then uses these to pull itself in one direction. If the adhesions at the 
rear of the cell are too strong then they will not detach easily from the surface and so
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the cell will not be able to move. It is for this reason that maximum cell movement 
occurs at intermediate peptide concentrations.117
The effect of clustering of the peptides on a surface has been investigated. It was 
found that clusters of RGD peptides enhanced the formation of stress fibres and 
increased the number of focal contacts compared to surfaces where the RGD was 
evenly spaced.82 Effective focal adhesions require integrin clustering and so it is 
likely that this is facilitated by the peptides in this case. The results also showed an 
increase in cell migration caused by the clustering. This was likely due to the more 
effective focal adhesions and more organised stress fibres.
The RGD sequence in fibronectin has been shown to be at the tip of a loop formed by 
disulphide bonding. For this reason it was hypothesised that cyclising the peptides 
may make them more effective at increasing the adhesion of cells. In a number of 
cases it was found that the cyclic peptides were more efficient at increasing cell 
adhesion and spreading than their linear analogues.94,101’118 This shows the 
importance of the conformation of the peptide in that it is more effective when 
presented to cells in a similar manner to when it's contained within the native protein.
Another method has been used to attempt to present the cell adhesion motif to the 
cells in the most natural conformation. By adding a tether or spacer molecule in 
between the peptide and the surface the peptide becomes less restricted in its 
movement. Its conformation is then determined solely by its structure with little 
effect from steric constraints due to the close proximity of the surface.119 As
23
mentioned previously, clustering of the peptides enhances their effect on cell 
adhesion. A spacer group would allow the peptides, and therefore integrins, to cluster 
and so may be another reason for the increased adhesion.
It is clear from these results that the way that the adhesion peptide is presented to the 
cells greatly affects the cellular response. In summary, altering one of the amino acids 
in the sequence changes the conformation of the peptide and reduces cell attachment. 
Making the peptide cyclic rather than linear increases cell attachment, as does adding 
a tether or spacer group between the surface and the peptide. These alterations make 
the peptide available to cells in a more similar way to that in which they would be 
available in the native protein. It is therefore likely that better cell attachment would 
be achieved by using the native protein itself rather than a small fragment of it. For 
this reason the covalent attachment of proteins to a surface has been investigated 
extensively.
1.1.3.3 -  Cell Adhesion Proteins
1.1.3.3.1 -  Methods of Attachment
As well as being an effective method for attaching peptides to a surface, 
carbodiimides have also been used to immobilise proteins. The reagent can activate 
the C-terminal of the protein for reaction with an aminated surface or alternately 
activate a carboxylated surface for reaction with protein amino groups. Collagen,
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gelatin, fibronectin, laminin, insulin and silk fibroin have all been attached to surfaces
. - . . .  . ,  , . . 50,51,56,57,65,120-125using carbodnmide chemistry.
Glutaraldehyde is a dialdehyde that is often used as a cross-linker. It can be used to 
attach proteins to a surface by reacting one aldehyde group with an amino group on 
the surface and the other with an amino group in the protein. This method has been 
used to immobilise collagen, fibronectin and gelatin to surfaces.64'67,126
Another method used to immobilise proteins is to plasma treat the surface and then 
immediately immerse it in a solution of the protein. The functional groups created by 
the plasma react directly with amino or carboxyl groups on the protein thus anchoring 
it to the surface. Collagen and laminin have been successfully attached to polymer 
surfaces using this method.44’46,125
Collagen has also been attached to a surface by treating the polymer with ozone and 
grafting acrylic acid to it. The carboxylic acid groups then act as a crosslinker to 
immobilise the protein under acidic conditions.55 Ozone treatment followed by direct 
immersion in a solution of collagen has also been used to attach the protein to a 
polymer surface.54
These modification methods have been used to successfully immobilise the 
mentioned proteins onto surfaces. These are the most commonly used proteins but 
there is no reason why the same methods couldn't be used to attach other proteins.
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1.1.3.3.2 -  Cellular Responses
The behaviour of cells cultured on protein-modified surfaces has been studied 
extensively. In order to get a more complete picture of the effects of different 
proteins, this section of the review will include the cellular response to adsorbed as 
well as covalently attached proteins.
Fibronectin is probably the most favoured protein used to control cell behaviour. It 
contains two well known cell binding motifs, RGD and REDV. These sequences are 
recognised by a number of cell surface integrins and so it is not surprising that 
significant increases in cell attachment to fibronectin-modified surfaces compared to 
controls have been seen in a number of studies.1,57,126'129 Increases in cell proliferation 
have also been demonstrated in much of the same work. The modulation of SMCs 
from a contractile to a synthetic phenotype has been shown to be triggered by 
culturing cells on a fibronectin-modified surface.2,129 Endothelial cells showed 
improved anti-thrombogenic and fibrinolytic properties when grown on fibronectin 
covalently attached to a polymer surface.47 This demonstrates that the endothelial cell 
phenotype is maintained on this surface.
Collagen type I is the most abundant type of collagen in the body. It contains a 
number of sites recognised by integrins.130 It is another protein that has been shown 
in many different studies to increase cell attachment to a surface. In each case the 
levels of cell adhesion were greater compared to unmodified control 
surfaces.45,50,56,64,65,67,120,121,126'129 In addition, an increase in the rate of proliferation
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has been identified on collagen-modified surfaces. However, there are also studies 
that show no change in cell growth.56’126 These conflicting results could be due to the 
varying methods of attaching the protein to the surfaces. The ability of collagen to 
maintain the function of endothelial cells has also been demonstrated. Cells cultured 
on this protein secreted enhanced levels of von Willebrand Factor, a marker of 
endothelial cell phenotype.64,65,67 In other work collagen was used to modify the 
surface of a porous polymer scaffold. Cells cultured on this infiltrated the pores and 
secreted large amounts of extracellular matrix. In contrast cells on the control scaffold 
stayed mainly on the surface.45
Collagen type II is the major form of collagen found in cartilage. For this reason its 
effect on chondrocytes is especially interesting. As with collagen I there are a number 
of cell binding sites within the protein. Crosslinked collagen II was found to increase 
cell proliferation when adsorbed on to a polymer surface compared to uncoated 
controls.131 This effect was seen for up to 60 days. Attachment and spreading of 
chondrocytes has been shown to increase on surfaces coated with collagen II
132 133compared to a negative control. ’
Collagen type IV is a major constituent of the basement membrane of cells. Both 
urothelial cells and fibroblasts have shown greater attachment to the protein 
compared to controls.134,135 In addition to this, the effect of a collagen IV substrate 
on smooth muscle cells has been investigated. SMC phenotype is greatly affected by 
the surface on which the cells are cultured. The protein slowed down the modulation 
of the cells from a contractile to synthetic phenotype for approximately 4 days. A
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combination of collagen IV and laminin, the other main protein in the basement
membrane, has also been shown to maintain the SMCs in their native contractile
1phenotype when cultured in vitro.
Equally, SMCs cultured on laminin alone have also been shown to maintain a more 
contractile phenotype compared to uncoated surfaces and those coated with 
fibronectin or vitronectin.1,2 However, one of these studies showed low initial 
attachment of the cells and this result is backed up by other work that shows low 
levels of attachment of urothelial cells.134 In contrast fibroblasts have exhibited high 
levels of attachment to laminin compared to negative controls.135 A number of cell 
adhesion peptide sequences have been identified in laminin. These include YIGSR 
and IKVAV. Integrins containing the Pi sub-unit are major mediators of this cell 
adhesion.137 Laminin has been shown to promote neurite outgrowth from cultured 
neurons.118'138 It has also been shown to greatly increase hepatocyte, Schwann cell 
and olfactory ensheathing cell adhesion compared to un-coated controls.139'140
Elastin is a major constituent of the elastic fibres found in elastic tissue such as blood 
vessels and skin. It is formed by the cross-linking of its soluble precursor, 
tropoelastin. A number of cell binding sites on the protein have been proposed. 
Elastin-based surfaces have been shown to support the attachment of a number of 
different cell types.141 In some studies there was evidence to show that this 
attachment was, in part, mediated by the elastin-binding protein on the cell 
surface.142’143 The effect of elastin surfaces on SMC phenotype has been investigated 
in a number of studies. In each case the cells appeared to have a more contractile
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phenotype, characterised by decreased proliferation and higher amounts of contractile 
filaments.144,145 In one case endothelial cell proliferation was seen to increase whereas 
the rate of SMC proliferation decreased on surfaces with a fairly low elastin
. 146concentration.
Fibrillin-1 is another protein of interest found in elastic fibres. This is a large 
glycoprotein that contains an RGD motif along with other cell binding areas. A 
number of cell types have been shown to attach to fibrillin-1 via the RGD motif. 
There is a great deal of evidence to suggest that this interaction is mediated, at least in 
part, by the a vp3 integrin.147'148 149,150 Some studies have also demonstrated the 
involvement of the asPi and, for epithelial cells, the avP6-151 153 Cell adhesion and 
spreading were enhanced on the fibrillin compared to negative controls.
Fibulin-5, or DANCE, is a glycoprotein that is also a component of elastic fibres. It 
contains an RGD motif and cell attachment has been shown to be dependent on 
integrin binding to this sequence.154,155 The involvement of the integrin a5Pi and the 
subunit av in endothelial cell attachment has been demonstrated in one study. In 
another, using smooth muscle cells, the contribution of the avp3 integrin was 
discounted. This study showed the major integrins involved in the attachment of 
SMCs to fibulin-5 were a5Pi and a4pt. The protein has was shown to support a degree 
of cell spreading whilst decreasing proliferation and migration compared to 
fibronectin.156
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1.1.4 -  Conclusions
Modifying polymer surfaces has been shown to be an effective way of increasing cell 
attachment. It has also been demonstrated that some proteins can control other aspects 
of cell behaviour such as proliferation, spreading, extracellular matrix production and 
cell phenotype. Surface modification with cell adhesion proteins is potentially an 
important tool for the development of a cell-seeded bypass graft.
1.2 -  The Hybrid Artificial Blood Vessel
1.2.1 -  Structure of the Native Artery
The outer layer of the artery is termed the tunica externa (Figure 5). It is made up of 
fibroblasts within a fibrous extracellular matrix consisting mainly of collagen. The 
function of this fibrous layer is to support and protect the vessel and to help anchor it 
to the surrounding tissue.
The tunica media consists of concentric layers of SMCs and elastic lamellae. The 
SMCs contract and relax in response to factors such as blood pressure and hormones. 
This allows control of the volume of blood flowing through the artery to be achieved 
by altering the lumen diameter. The elastic fibres are responsible for the elastic recoil 
property of arteries and they help prevent the over-extension of the vessel.
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The innermost layer of the artery consists of an endothelial cell monolayer that is 
separated from the tunica media by a basement membrane. The endothelial cells 
secrete anti-thrombogenic molecules such as prostacyclin and nitric oxide. These 
prevent platelet adhesion to the luminal surface of the blood vessel and subsequent 
thrombogenesis.
Epithelial Cells Tunica Intima -  
Endothelial Cells
Tunica Media -  
Smooth Muscle
Tunica Externa -  Loose 
Fibrous Connective Tissue Elastic Lamina
Figure 5 -  The structure of an artery. Adapted from (S.I. Fox, Human Physiology, 4th Ed, Brown
Publishers)
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1.2.2 -  Structure of the Hybrid Artificial Blood Vessel
The artificial blood vessel aspired to in this work is based on a porous, tubular 
scaffold (Figure 6). This is formed by the electrospinning of a non-degradable 
polyurethane elastomer. The polymer is biostable and would remain in the body 
permanently in order to remove the need for the newly grown tissue to withstand the 
large physiological pressures. The artery would therefore need less in vitro culture 
time making the process more cost effective.
Autologous vascular SMCs taken from a vein biopsy or derived from adult stem cells 
form a layer on the internal surface of the tubular scaffold. These are seeded on to the 
polymer surface in vitro and cultured in a bioreactor. The polymer is modified by 
covalently attaching recombinant proteins to the surface. These proteins serve to 
increase cell adhesion and gain a degree of control over the cells' behaviour including 
proliferation, protein production and phenotype. Endothelial cells are then cultured on 
top of the smooth muscle cells with the aim of forming a non-thrombogenic layer as 
the blood contacting surface. On the outside of the polymer tube is a layer of 
fibroblasts. The aim of these is to prevent aneurysm. This has previously been shown 
to be a problem with polyurethane grafts.17
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Polymer Scaffold Covered with 
Fibroblasts
Internal Scaffold Surface 
Modified with Proteins
Smooth Muscle Cells Layer of Endothelial 
Cells
Figure 6 -  Diagram of the proposed structure of the artificial artery. (Adapted from S.I. Fox, 
Human Physiology, 4th Ed, Brown Publishers)
This project will specifically focus on the interface between the polymer scaffold and 
the SMCs. Proteins will be covalently attached to the surface and the behaviour of the 
cells cultured on it investigated.
1.2.3 -  Polyurethanes
Polyurethanes are a class of polymers that are formed from the reaction of a 
diisocyanate with a polyol (Figure 7). Different monomers can be used along with 
various chain extenders to give materials with a wide variety of chemical and
• 157physical properties.
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0 ^ = C = N ------ R-------N ^ = C = 0
+
OH-------R'------ OH
Figure 7 -  General reaction to synthesise a polyurethane
The polyurethane structure consists of hard segments that are polar and immobile due 
to hydrogen bonding and soft segments consisting of non-polar, randomly coiled 
domains, often aliphatic polyethers or polyesters. The differences in the chemical 
properties of the segments cause them to phase separate. In response to an applied 
stress the coiled, soft segments partially unravel while the hard segments become 
aligned. Because of this just a small amount of stress can result in a large deformation 
of the polymer (Figure 8). Additional increases in stress cause further elongation of 
the polymer. When the stress is removed the polymer returns to its original state due 
to its elastic properties. The polymer has both viscous and elastic properties and so is 
termed viscoelastic.
Strain
Figure 8 -  Typical stress-strain behaviour of a polymeric elastomer
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Compliance mis-match is thought to be a major factor in the failure of small diameter 
artificial bypass grafts. Dacron, for example, has almost no stretch in any direction in 
dramatic contrast to the native artery that it would be sutured to. This causes 
disruption of the pulsatile flow and increases the likelihood of neointimal hyperplasia. 
This is characterised by the migration and proliferation of smooth muscle cells from 
the tunica media and causes the diameter of the graft to decrease significantly. In 
order to reduce this problem it is necessary to use a polymer that has physical 
properties similar to those of the native artery i.e. viscoelasticity. For this reason a 
range of polyurethanes are being investigated as potential bypass graft materials.
In this work a polyether-urethane, b9 Z1A1 (Biomer Technologies Ltd), will be 
investigated. Polyether-urethanes are hydrolytically stable and so are good candidates 
for implantation into the body. This particular polyurethane has a high ultimate 
tensile strength and ultimate elongation. It therefore has the necessary strength and 
compliance for this application.
1.2.4 - Cell Adhesion Proteins
It is hypothesised that by modifying the polymer surface with proteins found in the 
artery wall, the cells cultured on it will be encouraged to secrete and organise 
extracellular matrix and produce an environment similar to that of a native artery. 
This environment may then control the phenotype of the SMCs preventing them from
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over-proliferating and blocking the graft. It would also be beneficial for the produced 
extracellular matrix to support the formation of a confluent layer of endothelial cells.
The proteins investigated here are a fragment of fibrillin-1 and full length 
tropoelastin. These are major constituents of the elastic fibres found in the artery wall. 
Fibrillin-1 molecules assemble into microfibrils.158'160 Bundles of these then form a 
template for tropoelastin deposition. Elastic fibre formation proceeds by the 
crosslinking of the tropoelastin to form insoluble elastin. Other molecules, including 
fibulin-5 and MAGP-1, associate with the microfibrils and the elastin facilitating the 
construction of the elastic fibres.161’163
1.2.4.1 - Fibrillin-1
Fibrillin-1 is a large glycoprotein (~350kDa) that consists of 47 epidermal growth 
factor-like domains, 43 of which are calcium-binding (cbEGF-like domains) and 7 8- 
cysteine transforming growth factor beta-like (TB) domains. Present in the 4th TB 
domain (exons 37-38) there’s a cell binding domain, Arg-Gly-Asp (RGD). This has 
been found to be the minimum amino acid sequence necessary for integrin binding.39 
It is thought that over half of the known integrins recognise the RGD motif. A 
number of RGD-containing fragments of fibrillin-1 have been recombinantly 
expressed by researchers at the University of Manchester (Figure 9). These protein 
fragments have been adsorbed onto tissue culture plastic and cell attachment studies 
have been carried out. It was found that superior cell binding was achieved on 
fragments with domains present upstream of the RGD motif i.e. PF8 and PF14.151 
This suggests that there is a synergy binding site present in this area that is required
36
for efficient cell binding. Other work has shown that the integrins aspi and avP3 are 
the major receptors involved in mediating cell attachment to these fibrillin-1 
fragments.148 In this work PF14 was chosen due to the presence of both the RGD 
sequence and the proposed upstream synergy site.
|  Unique N-terminus Q  TB module
|  Ca2*EG F domain ®  Pro-rich motif
A
y  Hybrid domain ^  N-Glycosylation
H  EG F domain
PF14
Figure 9 -  Domain structure of recombinant fibrillin-1 fragments
1.2.4.2 - Tropoelastin
Tropoelastin is the soluble precursor to elastin. It is a 65-70 kDa protein that makes 
up approximately 90% of the elastic fibre.164 It consists of alternating hydrophobic 
and lysine-rich cross-linking domains.165 It is secreted by cells and deposited onto a 
lattice of fibrillin microfibrils. It is then cross-linked by enzymes of the lysyl oxidase 
family to form the insoluble elastin. As mentioned previously (section 1.3.3.2) a 
number of cell-binding sites on tropoelastin have been proposed.166 One is said to be
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near the C-terminus of tropoelastin with cell attachment mediated by the avp3 
integrin.167 In other work a binding site was identified, again at the C-terminus, but in 
this case cell attachment was not integrin mediated.168 In a more central area of 
tropoelastin there is a binding site recognised by the cell surface elastin binding 
protein (EBP). The peptide VGVAPG is thought to be the sequence responsible.169'170 
Full length tropoelastin has been recombinantly expressed using E. coli.171 This 
protein has been chosen due to its sizeable presence in the elastic fibres of the artery 
wall and its cell-binding properties.
Signal Peptide
Hydrophobic Domain
Q  KP-Rich Crosslinking Domain
I  KA-Rich Crosslinking Domain
C-Terminal Sequence
Figure 10 -  Domain structure of tropoelastin
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1.2.5 - Vascular Smooth Muscle Cells
Smooth muscle cells make up the medial layer of arteries. They form concentric 
layers alternating with elastic laminae. In vivo vascular SMCs have a contractile 
phenotype. They do not proliferate and produce very little extracellular matrix. 
Disruption of the SMC basement membrane triggers a phenotypic transformation. 
The cells acquire the ability to proliferate, migrate and synthesise extracellular 
matrix.4’172
This same transformation occurs during in vitro culture of SMCs.173’174 In the first 
few days of culture the cells undergo a number of alterations. The number of 
myofilaments decreases and their ability to contract, either spontaneously or with 
chemical induction, disappears. There is an increase in ribosomes and rough 
endoplasmic reticulum indicating the cells have achieved the ability to synthesise 
extracellular matrix proteins. The cells change from bi-polar to a more fibroblast-like 
morphology.1,175
Figure 11 -  Illustration of the morphology of the 2 different smooth muscle cell phenotypes;
contractile (A) and synthetic (B)
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The phenotype of SMCs in culture can be monitored by various methods. Observing 
the morphology of the cells is a basic but effective way of approximating their 
phenotypic state. Figure 11 shows the difference in appearance of the 2 distinct cell 
phenotypes. However, it is likely that a SMC in culture will be in an intermediate 
state and so this method is restricted. Looking at the rate of proliferation can also give 
a general idea of the level of transformation of the cells. Contractile SMCs do not 
proliferate whereas synthetic cells do. Again this method does not give a clear picture 
of the phenotypic state of the SMCs. To get a more accurate representation of the 
SMC transformation the observation of a number of protein markers is needed. This 
can either be achieved by semi-quantitative methods such as Western blotting or by 
imaging of the cells using immunostaining.
The level of smooth muscle a-actin decreases during the modulation of SMCs from a 
contractile to a synthetic phenotype.176,177 178 180 In parallel to this the level of (3-actin 
increases. 181 Smooth muscle myosin heavy chain and tropomyosin expression 
decrease.177’179'181 The level of meta-vinculin increases during the transformation 
whereas the related protein vinculin decreases.176,179'181 Desmin, calponin, SM22-a 
and the ai integrin have all been found to be at lower levels in synthetic 
SMCs.176,177,179 183 Heavy caldesmon is decreased whereas light caldesmon 
increases.176,177,179,180 Smoothelin is a protein only found in contractile SMCs and so 
is a good marker for this phenotype.184'186
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1.2.6 -  Specific Aims and Objectives
This project has four main aims.
1 -  Can the fibrillin-1 fragment and the tropoelastin be covalently attached to 
the polyurethane via this surface modification protocol?
A protocol has previously been developed in order to covalently attach cell 
adhesion peptides such as GRGDSPK to a polyurethane surface.187 This protocol has 
been adapted in order to attach proteins rather than peptides. In addition to this a 
different polyurethane is used. Each step of the modification was assessed and 
optimised using various chemical and biological techniques. The attachment of the 
proteins was verified using Enzyme-Linked Immunosorbent Assays.
2 -  Is the conformation of the proteins adversely affected by the covalent 
attachment process?
The attachment of cells to these proteins adsorbed onto tissue culture plastic 
has been investigated. In the work presented here the attachment of cells to the 
covalently bound proteins was assessed. The results were compared in order to 
determine whether or not the modification protocol adversely affects the cell-binding 
properties of the proteins. If the conformation of the protein is altered a great deal by 
the attachment process then certain binding sites that are available on the adsorbed 
protein may not be available on the bound protein.
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The RGD-dependence of cell attachment to fibrillin-1 was investigated as was the 
involvement of the a5Pi and avP3 integrins. The involvement of the a vP3 integrin in 
cell attachment to tropoelastin was also examined
3 -  How is the behaviour of the cells affected by the protein-modified surfaces?
The behaviour of human coronary artery smooth muscle cells cultured on the 
modified surfaces was investigated qualitatively and quantitatively in detail. The 
effects of the two proteins were compared to each other and to plain, un-modified 
polyurethane.
Cell proliferation and spreading on the surfaces was investigated. RT-PCR was used 
to examine the expression of various genes by cells cultured on the surfaces including 
extracellular matrix proteins, basement membrane proteins and phenotypic markers. 
The synthesis of the same proteins was investigated using immunostaining and 
western blotting.
4 -  What are the implications of this research for the development of an 
artificial bypass graft?
The results of the experiments were used to determine the value of this surface 
modification for use in developing a hybrid artificial artery.
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Chapter 2 - Materials and
Methods
2.1 -  Materials
Human embryonal kidney 239-EBNA cells were transfected and grown at the 
University of Manchester. Nickel affinity chromatography columns were purchased 
from GE Healthcare, Buckinghamshire, UK. NuPAGE® lithium dodecyl sulphate 
buffer (4X), Sample Reducing Agent (10X), Novex 4-12% bis-tris gels and 
SimplyBlue™ SafeStain were purchased from Invitrogen, Paisley, UK. The Precision 
Plus Protein™ Standard was purchased from BIO-RAD, Hertfordshire, UK. The 
tropoelastin was a gift from Professor Anthony Weiss at the University of Sydney, 
Australia.
b9, Z1A1 polyurethane was obtained from Biomer Technologies Ltd, Runcorn, UK. 
Dextran (MW = 10,000) was purchased from PharmacosmosA/S, Denmark. 
Dimethylacetamide, polyethyleneimine (50%w/v in H2O, MW = 750,000), sodium 
periodate, sodium cyanoborohydride coupling buffer, phosphate buffered saline 
tablets, fluorescamine, dextran-FITC (FITC:Glucose = 1:100), ABTS (2,2'-Azino- 
bis(3-ethylbenzothiazoline-6-sulfonic acid) and bovine serum albumin were 
purchased from Sigma-Aldrich, Dorset, UK.
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Cryopreserved human coronary artery smooth muscle cells were purchased from 
Cascade Biologies, Nottingham, UK, along with medium 231, smooth muscle growth 
supplement (SMGS) and trypsin/EDTA. Penicillin/streptomycin and GRGDSPK 
peptide were purchased from Sigma-Aldrich, Dorset, UK. Monoclonal antibody to 
fibrillin-1 was synthesised in the School of Biosciences at the University of 
Manchester, UK. Mouse anti-polyHistidine monoclonal antibody was purchased from 
R&D Systems, Abingdon, UK. Mouse anti-CD51 (272-17E6) and anti-CD61 
(290.5C10) monoclonal antibodies were purchased from Calbiochem, Nottingham, 
UK. Mouse anti-CD49e (JBS5) monoclonal antibody was purchased from AbD 
Serotec, Oxford, UK. Mouse anti-CD29 (mAbl3) monoclonal antibody was 
purchased from BD Biosciences, Oxford, UK. Mouse anti-CD51/61 (LM609) 
monoclonal antibody was purchased from Chemicon, Hampshire, UK. Rabbit anti­
mouse IgG and goat anti-rabbit IgG polyclonal horseradish peroxidase conjugates 
were purchased from DAKO, Cambridgeshire, UK. Monoclonal antibodies to a- 
smooth muscle actin, elastin, calponin, laminin and collagen IV were purchased from 
Sigma-Aldrich, Dorset, UK. Monoclonal antibodies to caldesmon, fibulin-5 and 
smoothelin were purchased from AbCam, Cambridge, UK. Monoclonal anti-fibrillin- 
1 antibody was purchased from AbD Serotec, Oxford, UK. The Quant-iT™ 
PicoGreen® DNA quantification assay was purchased from Invitrogen, Paisley, UK. 
Primers for RT-PCR were purchased from Invitrogen, Paisley, UK. The DNase I 
Amplification Grade, Oligo(dT)20 Primer, dNTP Mix, RNaseOUT Recombinant 
Ribonuclease Inhibitor and Superscript III Reverse Transcriptase PCR kits were 
purchased from Invitrogen, Paisley, UK. The iQ SYBR Green Supermix was 
purchased from BioRad, Hertfordshire, UK. The Western blot Mini Protean 3 system
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was purchased from BioRad, Hertfordshire, UK. The Laemmli Sample Buffer was 
purchased from Sigma Aldrich, Dorset, UK. The MagicMark™ XP Western Standard 
and the SeeBlue® Plus2 Prestained Standard were purchased from Invitrogen, 
Paisley, UK.
The FLX800 and p Quant plate readers were purchased from BIO-TEK Instruments, 
VT, USA. Cell images were captured by a Zeiss Axioplan 2 microscope fitted with an 
axiocam digital camera. Confocal images were acquired using a Zeiss LSM500. The 
GeneGnome Western blot visualisation system was purchased from Syngene, 
Cambridge, UK.
2.2 - Recombinant Protein Synthesis and Purification
The fibrillin-1 fragment PF14 was produced using an episomal expression system and 
293-EBNA cells as previously described.148 The vector used was pCEP-pu/AC7 and 
this was modified with a polyHistidine6 tag at the N-terminal to allow purification 
using nickel affinity chromatography. Cells were transfected at the University of 
Manchester, UK.
After transfection the 239-EBNA cells were cultured in DMEM-4 medium 
supplemented with 10% (v/v) foetal calf serum, 1% (w/v) penicillin/streptomycin, 
geneticin (300pg/ml) and puramycin (5pg/ml). When confluent, the medium was 
removed and the cells were washed with PBS. T6 medium was then added and the
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cells were cultured for a further 3 days. After this time the medium was taken off and 
any dead cells were removed by centrifugation. Protease inhibitors were then added 
to the medium. The liquid was dialysed into 51itres of salt buffer (5.68g Na2H P04, 
5.52g NaH2P 0 4, 116.88g NaCl, 2.72g imidazole, 51 H20 ) for 3 days with a change of 
buffer every day. It was then pumped through a 1ml nickel column. The column was 
washed with 100ml of salt buffer before the protein was eluted as 1ml aliquots in 
elution buffer (1.42g Na2H P04, 1.38g NaH2P 0 4, 29.22g NaCl, 34.04g imidazole, 11 
H20).
Analysis of the protein fragment was carried out by analytical SDS polyacrylamide 
gel electrophoresis. The protein was analysed in both a reduced and non-reduced 
form. 10[xl of 4X lithium dodecyl sulphate (LDS) buffer was added to 30pl of 
protein. 4p,l of reducing agent was added to the samples to be reduced. All samples 
were placed in boiling water for 2 mins, mixed briefly and centrifuged for 2 mins at 
8,000rpm. 40^1 of each sample was run against a broad range molecular weight 
standard at 200V for 1 hr. The gels were then stained with SimplyBlue™ SafeStain 
and washed with distilled water before imaging.
The eluted aliquots that contained the protein as identified by SDS-PAGE were 
dialysed in PBS to remove the imidazole. The absorbance was read at 280nm and the 
corresponding protein concentration was calculated according to Beer's Law. (A=ecl, 
taking e as 1). The protein was then frozen at -80°C until use.
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The tropoelastin was synthesised at the University of Sydney, Australia using a 
bacterial expression system.188 The lyophilised protein was dissolved in phosphate 
buffered saline to the required concentration.
2.3 - Surface Modification Protocol
Polyurethane films were produced by spin-coating a 10% (w/v) solution of the b9 
polymer in dimethylacetamide (DMAc) on to 13mm glass discs. The surface was 
then functionalised using a reversible swelling technique. A solution of 3.5% 
polyethyleneimine (w/v) in a 1:1 ratio of DMAc and water was prepared and added to 
the polymer-coated discs. The discs were left for 3 days at 40°C in the absence of 
light. After this time an excess of water (non-solvent) was added to trap the 
polyethyleneimine leaving amine groups present on the surface of the polyurethane. 
The discs were then washed thoroughly with distilled water and dried at 40°C to 
remove any residual solvent.
A solution of dextran (MW=10,000) in water was prepared (3g, 100ml H20). A cold 
solution of sodium periodate (3g, 100ml H20 ) was then added to this with vigorous 
mixing. The mixture was left stirring overnight at 4°C in the absence of light. A 
reductive animation reaction was used to attach the dextran to the amine groups. The 
partially oxidised dextran solution was added to the animated polyurethane discs with 
an equal volume of sodium cyanoborohydride coupling buffer to quench the Schiff 
bases and stabilise the nitrogen-carbon bonds. The discs were then left overnight on a
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mechanical shaker at room temperature. The dextran/NaCNBH3 mixture was 
removed and the discs were washed thoroughly with distilled water (Figure 12).
A solution of NaIC>4 (0.6g, 100ml H20 ) was then added to the dextran-coated discs to 
form aldehyde groups on the dextran layer surface. The discs were immersed in the 
oxidising solution on a mechanical shaker overnight at room temperature before 
being washed thoroughly in distilled water.
The discs were then placed in the wells of a 24-well plate and sterilised by exposure 
to UV/O3 for 20 seconds. The proteins were dissolved in sterile PBS to the required 
concentration. 500|xl of this solution was added to each well along with an equal 
volume of NaCNBH3. The plates were placed on a mechanical shaker overnight at 
room temperature. The solution was then removed from the wells and the discs were 
washed with sterile PBS (Figure 13).
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Figure 12 -  Dextran attachment to the aminated polyurethane surface
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Figure 13 - Attachment of the protein to the dextran layer
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2.4 -  Cell Culture
Cryopreserved human coronary artery smooth muscle cells were cultured in medium 
231 with the addition of a smooth muscle cell growth supplement (SMGS) (foetal 
bovine serum (4.9% (v/v) final concentration), human basic fibroblast growth factor 
(2 ng/ml), human epidermal growth factor (0.5 ng/ml), heparin (5 ng/ml), insulin (5 
pg/ml), BSA (0.2 pg/ml)). 5ml of 50X penicillin-streptomycin (5,000 units/ml, 
5mg/ml, respectively) was also added. Cells were passaged every 7 days using 
trypsin/EDTA (Cascade Biologies). They were grown in T75 tissue culture treated 
flasks seeded at a density of 5 x 103 cells/cm2. Cells were used between passages 3 
and 6.
2.5 - Surface Analysis Protocols
2.5.1 -  Assessment of Amination
The presence of amine groups on the polyurethane surface was assessed using a 
solution of fluorescamine. This is a molecule that selectively reacts with primary 
amines to form a fluorescent conjugate (Figure 14).189 Discs of aminated and plain 
polyurethane were added to a black 96-well plate (6 discs per surface). A solution of 
fluorescamine was prepared (4.5 x 10'3M) and 100|a.l of the solution were added to 
each well. The fluorescence was measured at Xex=360nm, )^m=460nm.
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Figure 14 - Reaction of fluorescamine (A) with the amino terminal of a protein to form a
fluorescent adduct (B)
2.5.2 -  Assessment of Dextran Attachment
The efficacy of the covalent attachment of the dextran was investigated using a 
dextran-FTTC conjugate. The dextran-FITC was dissolved in water (lOmg, 2ml H2O). 
This solution was split into 2, an equal volume of sodium periodate was added to one 
sample to partially oxidise the dextran and an equal volume of water was added to the 
other to act as a control. The solutions were left to stir at 4°C in the absence of light 
for 1 hr. Discs of aminated polyurethane were placed in the wells of a black 24-well 
plate. The oxidised and non-oxidised dextran-FITC solutions were added to the discs
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along with an equal volume of NaCNBH3 (8 discs per solution). The discs were left 
on a mechanical shaker at room temperature for 3 hrs. After this time had elapsed the 
dextran solutions were removed and the discs were washed once with distilled water. 
The fluorescence of the discs was measured using a FLX800 fluorescence plate 
reader (XeX=485nm, Acm=525nm). The discs were then washed repeatedly with the 
fluorescence being measured between each wash.
The optimal degree of dextran oxidation was determined as being the level at which 
cell attachment to the surface was at its lowest. 5ml aliquots of dextran were 
prepared, each containing 0.15g. An equal volume of different concentrations of 
N aI04 was added to each aliquot. The pH of each solution was measured after 30 
mins, 1 hr and after being left to stir overnight. Each solution was then added to 
aminated polyurethane discs with an equal volume of NaCNBH3 coupling buffer. The 
samples were then left overnight for the dextran to attach. The discs were washed and 
sterilised using UV/O3 for 20 secs. Human coronary artery smooth muscle cells were 
seeded on to the surfaces at a density of 2.5 X 104 cells/well in serum-containing 
medium (see section 2.4 for details of the cell culture protocol). After 3 and 24 hrs the 
cells were fixed with formaldehyde/sucrose and stained with 0.4% (w/v) methylene 
blue for 10 mins. Representative images of the cells were taken at 10X magnification 
using an axiocam digital camera attached to an axioplan microscope.
2.5.3 -  Enzyme-linked Immunosorbent Assays
Increasing concentrations of the protein were added to the dextran- coated discs in the 
final step of the modification (1, 2, 5 and lOpg/ml, 3 discs each). The first step of the
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ELISAs was to block any non-specific antibody binding by adding 750p.l of bovine 
serum albumin (5%w/v in PBS) to each well. The samples were left for 30mins at 
room temperature. After washing 3 times with PBS, 500[xl of primary antibody at the 
required concentration was added to each well (fibrillin/elastin antibodies at lOpg/ml, 
RGD antibody at 5pg/ml). The samples were then left for lhr at room temperature 
before washing 3 times with PBS. 500^1 of 1:500 horseradish peroxidase-conjugated 
secondary antibody (polyclonal rabbit anti-mouse IgG) was added to each sample. 
The discs were then washed 3 times with PBS. A solution of ABTS (2,2'-Azino- 
bis(3-ethylbenzothiazoline-6-sulfonic acid) was prepared as follows. 1ml of 40mM 
ABTS in water and 2[rl of 30% hydrogen peroxide were added to 20ml of 0.1M 
sodium acetate/0.05M sodium dihydrogen phosphate (pH5). 500pl of the solution 
was then added to each sample and incubated at room temperature until a dark green 
colour appeared in the wells. The absorbance at 405nm was measured using a pQuant 
plate reader.
2.6 - DNA Quantification Assay
lOOfil of Triton-XlOO (0.1% in carbonate buffer, pHIO) was added to each well 
before freeze-thawing 3 times from -80°C to 37°C. 500pl of 200mM Tris-HCl, 20mM 
EDTA, pH 7.5 (TE) was added to each well followed by 500p.l of the PicoGreen 
reagent diluted 200 fold in TE. 4 x 100(xl aliquots were taken from each well and 
placed in a black 96-well plate. The fluorescence was read on a FLX800 plate reader
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(Xex = 480nm, tern = 520nm). A standard curve was generated by measuring the 
fluorescence generated by different dilutions of cells (Figure 15).
Figure 15 -  Standard curve to relate measured fluorescence to cell number
2.7 -  Integrili Blocking
2.7.1 -  Soluble Peptides
The RGD-dependence of cell attachment to the fibrillin-modified surface was 
investigated by using a soluble RGD-containing peptide. HCASMCs were cultured as 
previously mentioned (section 2.4). Cells were trypsinised and re-suspended in 
serum-free medium. Viable cell number was determined using trypan blue staining to 
eliminate dead cells before counting using a haemocytometer. Cells were diluted to a 
concentration of 5 x 104 cells/ml with serum-free medium. 6ml of cell suspension
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were placed into 4 vials. The peptide GRGDSPK was diluted with PBS and added to 
the vials to obtain concentrations of 0.5, 1, 5 and 10[ig/ml. The cells were incubated 
with the peptide at 37°C for 30 minutes before seeding onto the fibrillin-modified 
surfaces at lml/well (6 discs per peptide concentration). Cells without peptide were 
seeded onto both glass and the modified surface as controls. The cells were left to 
attach for lhr at 37°C. The number of cells attached to the surface after this time 
period was then determined as follows. The medium was removed and the cells were 
washed 3 times with PBS. The discs were then removed to fresh wells to eliminate 
any contribution from any cells attached to the surrounding tissue culture plastic. The 
DNA quantification assay, detailed in section 2.6, was used to calculate the amount of 
cells retained on each surface. The cell number was calculated using the equation 
generated from the graph in Figure 15. Attachment was presented as a percentage of 
the number of cells on the surface in the absence of any soluble peptide.
2.7.2 -  Anti-integrin Antibodies
Antibodies were used to investigate integrin involvement in cell attachment to the 
modified surfaces. Antibodies to the av, P3, as and Pi integrin sub-units and to the avP3 
integrin were diluted with PBS. A cell suspension at a concentration of 5 x 104 
cells/ml was prepared in serum-free medium and split into 6ml aliquots. Antibody 
was added to each aliquot to produce concentrations of 0.1, 0.5, 1 and 5pg/ml. The 
cells were incubated with the antibody for half an hour before they were seeded onto 
the modified surfaces (6 discs per antibody concentration). The fibrillin-modified 
surface was probed with the antibodies to the 4 integrin sub-units. For the tropoelastin 
just the antibody to the integrin avP3 was used due to the limited amount of
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tropoelastin available to prepare the samples. Cells containing no antibody were 
seeded onto both glass and the modified surface as controls. Cells were left to attach 
for lhr before the attachment was quantified using the PicoGreen reagent as before.
2.8 -  Methylene Blue Staining
5 x 104 cells were seeded onto plain polyurethane and protein-modified surfaces in 
serum-free medium. After 3 hrs the medium in each well was exchanged for smooth 
muscle cell growth supplement -containing medium (SMGS). At 3 hrs, 1 day and 4 
days the cells were fixed with formaldehyde/sucrose for 5 minutes at room 
temperature and stained with 0.4% methylene blue for 10 minutes before thorough 
washing with distilled water. Images of the cells on each surface were obtained using 
a Zeiss Axioplan 2 microscope fitted with an axiocam digital camera.
2.9 -  Cell Spreading Assay
SMCs were cultured as in section 2.4. The cells were suspended in serum-free 
medium at a density of 5 x 104 cells/ml. They were then seeded on to plain PU and 
protein-modified PU surfaces at 1ml cell suspension per well. After incubation for 3 
hrs the cells were washed with PBS, fixed with formaldehyde/sucrose for 5 mins and 
stained with 0.4% methylene for 10 mins. Images of the samples were taken at 20X 
magnification using a Zeiss Axioplan microscope fitted with an Axiocam digital
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camera. 30 representative images were taken of the cells on each surface. Analysis of 
the images was performed with the aid of NIH image analysis software "Image J as 
follows (Figure 16). The images were first converted to black and white (image B). 
Gaps in the cell images were present where the cells were at their most spread. To 
reduce the error due to this the gaps were first filled by the software (image C). They 
were then adjusted further by manually filling in gaps using the original image as a 
guide to ensure that any area covered by a cell was counted (image D). The number 
of cells in each image was then calculated by counting any objects containing 500 or 
more pixels. The total area covered by cells was also measured by the software. The 
area per cell was then calculated and an average taken for each surface.
Figure 16 -  Processing of images for analysis of cell spreading
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2.10 -  Cell Proliferation Assay
5 x 104 cells were seeded onto plain polyurethane and protein-modified surfaces in 
serum-free medium (8 discs per surface, per time point). After 3hrs the medium was 
exchanged for SMGS-containing medium. The Quant-iT™ PicoGreen® DNA 
quantification assay was used to determine the cell number after 3 hrs, 1, 2 and 4 
days, (see section 2.6 for DNA quantification protocol).
2.11 -  RT-PCR
Primers were designed for the extracellular matrix proteins fibronectin, fibrillin-1, 
elastin and laminin and the phenotypic markers smooth muscle a-actin and 
smoothelin using the Beacon Designer software (Table 1). The primers were 
optimised using cDNA dilutions and observing the melt curve to check for any 
primer dimers that would cause errors in the results.
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T a b l e  1  -  P r i m e r  s e q u e n c e s  a n d  r u n n i n g  t e m p e r a t u r e s
Primer Sequence Temperature
Fibronectin Sense
Anti-sense
5'-TCA TCC GTG GTT GTA TCA G-3' 
3'-GTC TCA GTC TTG GTT CTC C-5'
54.2°C
Fibrillin-1 Sense
Anti-Sense
5'-AGG CTG TG T AG A TGA GAA TGA  
ATG-3'
3'-GGC ACT CGT CCT GGT TGG-5'
56.5°C
Elastin Sense
Anti-sense
5'-GAG TTG GTG CTG GTG TTC-3' 
3'-AGG TGC TGA GAG GAG GAG-5'
56.2°C
Laminin Sense
Anti-sense
5-A C T  ATT GCC TCA TAT TGT CCT 
CTG-3'
3-C C A  ACA CTG CTC ACT TCT TOC­
S'
52.9°C
Smooth Muscle Alpha 
Actin Sense
Anti-sense
5'-TCC ACC TTC CAG CAG ATG-3' 
3-C C A  CAG GAC ATT CAC AGT TG-5'
53.6°C
Smoothelin B Sense
Anti-sense
5'-GAG TCC ATG AAC GAT GTG-3' 
3'-TCT CTT GAG CCA CTG TTG-5'
55.9°C
GAPDH Sense
Anti-sense
5'-GAA GGT GAA GGT CGG AGT-3' 
CAT GGG TGG AAT CAT ATT GGA A-
5'
53.5°C
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Cells were seeded on to glass, plain polyurethane, fibrillin and tropoelastin-modified 
surfaces at a density of 5 X 104 cells/well in 500p.l of serum-free medium (3 discs per 
surface, per time point). After 3 hrs 500pl of SMGS-containing medium was added to 
each well. Cells were cultured for 3, 6 and 24 hrs. At each time point the medium was 
removed and the cells were washed with PBS. The samples were moved to fresh 
wells to eliminate DNA being harvested from the cells growing on the tissue culture 
plastic. 500p.l of TRI-Reagent were added to each well. This was left at room 
temperature for 5 mins before being removed to DNase/RNase-free Eppendorfs.
lOOpil of chloroform was added to each sample before vortexing and then 
centrifuging at full speed for 5 mins. The clear upper liquid layer was removed to a 
fresh Eppendorf and 300pl of isopropanol was added. The samples were then 
centrifuged for 15 mins at full speed. After this time the supernatant was removed and 
500p.l of 100% ethanol was added. The samples were centrifuged at full speed for 5 
mins, the ethanol was removed then 200|il of 70% ethanol was added. The samples 
were spun at full speed for 2 mins then the ethanol was removed and the RNA pellet 
was re-suspended in 10pl of nuclease-free water.
The RNA product was then DNase-treated. l(il of 10X DNase I Reaction Buffer, 1 pi 
DNase I, Amp grade and 2(il of nuclease-free water were added to up to 8(ig of RNA. 
This mixture was then incubated at room temperature for 15 mins. The DNase I was 
then inactivated by the addition of lp l of 25mM EDTA solution. This was then 
heated at 65°C for 10 mins.
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cDNA was then synthesised from the RNA. 1 pi of oligo(DT), 1 pi of dNTP mix and 
1 l|i.l of water were added to each RNA sample. The mixture was then heated at 65°C 
for 5 mins, cooled on ice for 1 min and briefly centrifuged. 4pl 5X First strand buffer, 
l(xl 0.1M DTT, lp l RNaseOUT and lp l superscript III RT were added to each 
sample before heating at 50°C for 45 mins then at 70°C for 15 mins. Each cDNA 
sample was diluted by 1:10 in water and then frozen.
The cDNA was then tested with each of the previously mentioned primers (Table 1). 
Each primer mix was first prepared by adding lOfxl of sense and anti-sense to 80pl of 
nuclease-free water. For each well of the PCR plate to be used 7.5 pi of SYBR Green, 
4.5|xl of water and 1 pi of primer mix were added to an ependorf. The plate was set up 
by adding 13pl of this mixture and 2pl of cDNA to each well. The samples were 
added in triplicate. The plate was then added to the PCR cycler and run at the 
required temperature sequence for 45 cycles.
ACt values were calculated by taking the average GAPDH Ct value of each sample 
from the average gene of interest Ct value e.g. ACt = Ctiaminin -  CtGAPDH- An average 
ACt value was taken from the 3 repeats of each sample. The 2'ACt value for each 
sample was taken from this and plotted on a graph.
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2.12 -  Immunostaining
2.5 x 104 cells per well were seeded on to plain and protein-modified PU surfaces in 
500pl of serum-free medium. After 3 hrs 500p,l of SMGS-containing medium was 
added to each well. The cells were cultured for 2 and 4 days. After each time point 
the cells were washed with PBS and fixed with formaldehyde/sucrose for 10 mins at 
37°C. The cells were washed and then permeabilised by adding lOOpl of 1% Triton- 
X I00 in PBS and incubating for 5 mins at 4°C. The Triton solution was removed and 
the cells washed with PBS. The first primary antibody was diluted to the required 
concentration in 1% (w/v) BSA in PBS. Optimal antibody concentrations were 
determined by staining SMCs cultured on glass discs (Table 2). 200pl of the antibody 
was then added to each well. The samples were incubated at 37°C for 1 hr and then 
washed 3 times with PBS. The secondary antibody (AlexaFluor 488) was diluted to 
the required concentration with 1% BSA in PBS. 200pl of this was then added to 
each well and the samples were incubated at 37°C for 1 hr. The samples were 
mounted onto glass slides using a drop of vector shield mounting medium containing 
DAPI nuclear stain. The samples were then visualised using a confocal microscope.
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T a b l e  2  -  A n t i b o d y  C o n c e n t r a t i o n s  U s e d  f o r  I m m u n o s t a i n i n g
Antibody Dilution
a5 1:100
(31 1:100
av(33 1:100
Vinculin 1:250
Laminin 1:100
Collagen IV 1:100
Fibulin-5 1:1000
Tropoelastin 1:100
Fibrillin-1 1:100
SMA 1:100
Calponin 1:100
Caldesmon 1:100
Smoothelin 1:100
AlexaFluor488 1:500
2.13 -  Western Blot Analysis
SMCs were seeded on to modified and plain PU surfaces at a density of 5 X 104 
cells/well in serum-free medium. After 3 hrs the medium was exchanged for growth 
supplement-containing medium. After a further 21 hrs, 500pl of SDS lysis buffer was 
added to the sample-containing wells. The cells were scraped from the surface and 
the solution removed to an Eppendorf. The samples were then heated at 100°C for 5 
minutes.
A 10% polyacryamide gel was prepared. The running gel was made by mixing 4ml 
separating buffer, 5.3ml acrylamide, 6.7ml water, 75pl 10% ammonium persulphate 
(APS) and 15 pi TEMED in a vial. The gel was then poured into a glass mould until it
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was half full. The mould was then topped up with water. The gel was allowed to set 
at room temperature before the water was removed. The separating gel was then 
prepared and comprised of 1.5ml stacking buffer, 1ml acrylamide, 3.5ml water, 50p.l 
10% APS and 15^1 TEMED. This was then added to the mould on top of the running 
gel. A comb was placed in the top of the gel and it was allowed to set at room 
temperature. The comb was removed and water was added to keep the wells intact.
Equal amounts of each sample and Laemmli buffer were added to Ependorfs and 
heated at 100°C for 5 mins. The wells of the gel were loaded with a SeeBlue® Plus2 
pre-stained marker (10p,l), MagicMark™ XP Western Standard (lOpil) or sample 
(25(rl). The gel was then secured in a tank filled with Tris-glycine buffer containing 
SDS and run at 80mA for 30 mins. The gel was then removed from the tank and 
placed in Tris-glycine buffer (without SDS).
The blot was then transferred on to a cellulose membrane. The membrane was soaked 
in methanol and then Tris-glycine buffer before being placed on top of the gel. These 
were then sandwiched between blotting paper and then sponge, both having been 
soaked in the Tris-glycine buffer. The gel sandwich was then secured in a tank 
containing Tris-glycine buffer and run at 300mA for 2hrs. After this time the 
membrane was placed into 3% (w/v) BSA in TBS-T buffer (lOmM Tris buffer 
(pH7.4), 0.1M NaCl, 0.1% v/v Tween 20) for 1 hr at 4°C. The membranes were then 
probed by various antibodies.
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The proteins examined in this way were the extracellular matrix proteins fibrillin-1, 
tropoelastin and fibulin-5; the basement membrane proteins laminin and collagen IV 
and the phenotypic markers smooth muscle a-actin, smoothelin, calponin and 
caldesmon. GAPDH was used as the control to normalise the protein concentrations 
calculated.
The primary antibody was diluted to 1:1000 in 3% (w/v) BSA in TBS-T. The 
membrane was placed into the solution and incubated at 37 C for 30 mins. The 
membrane was then washed 3 times with TBS-T for 5 mins. The horse radish 
peroxidase-conjugated secondary antibody was diluted to 1:2000 in 3% BSA and 
added to the membrane. This was then incubated at 37°C for 30 mins before being 
washed 3 times in the TBS-T buffer. The membrane was then placed in a solution of 
immobilon western chemiluminescent HRP substrate for 10 mins. The membrane 
was then placed on the tray of the GeneGnome chemiluminescent detection system. 
An image was collected for 5 mins. The contrast and brightness of the images were 
altered to obtain the clearest picture.
2.14 -  Statistical Analysis
Statistical analysis was carried out using an unpaired t-test to compare two samples. 
A p value of <0.01 was considered to be significant and a p-value of <0.005 was 
considered to be highly significant.
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Chapter 3 - Results
3.1 -  Protein expression and purification
A fragment of fibrillin-1 (PF14) was recombinantly expressed and purified using 
nickel affinity chromatography. The molecular weight of the fragment was verified 
using SDS-PAGE. Figure 17 shows an image of the gels containing protein samples 
from the first 5 aliquots collected from the chromatography column. The figure 
shows both the reduced and non-reduced protein samples. It is clear that the highest 
concentration of protein was collected in aliquots 2-4. These aliquots were combined 
to give an overall protein concentration of 1.14mg/ml.
Figure 17 - SDS-PAGE gels of purified fibrillin-1 PF14 aliquots eluted from a nickel affinity 
chromatography column
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3.2 -  Surface analysis
3.2.1 -  Assessment of amination
Primary amine groups were produced on the polyurethane surface by using a 
reversible swelling technique to incorporate polyethyleneimine into the surface layer. 
The level of amination was assessed by adding a solution of fluorescamine to plain 
and aminated polyurethane samples. Figure 18 shows the degree of fluorescence 
emitted from the plain and aminated surfaces on the addition of the fluorescamine. A 
degree of background fluorescence from the plain polymer is evident; however the 
difference between the plain and aminated surfaces is highly statistically significant 
(p < 0.005).
Figure 18 - Fluorescence emitted from discs of plain and aminated polyurethane on the addition 
of fluorescamine (*p £ 0.005)
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3.2.2 -  Assessment of dextran attachment
A layer of dextran was attached to the aminated polyurethane by partially oxidising a 
solution of dextran and immobilising it via a reductive amination reaction. The 
presence of the dextran layer on the surface was verified using a dextran-FITC 
conjugate. Figure 19 shows the fluorescence emitted from the polymer discs modified 
with either oxidised or non-oxidised dextran-FITC. After the removal of the dextran 
solution the samples were washed a number of times and the fluorescence measured 
after each wash. For oxidised dextran the initial fluorescence recorded was extremely 
high. After approximately 4 washes the measurements even out at around 2,500 units. 
In contrast the fluorescence emitted from the discs modified with non-oxidised 
dextran drops significantly after just 2 washes and remains at a constant level of 
around 500 units.
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Figure 19 -  Fluorescence levels due to the retention of oxidised and non-oxidised dextran-FITC 
by aminated polyurethane surfaces after washing
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The level of oxidation of the dextran solutions was assessed by monitoring the 
change in pH caused by the formation of methanoic acid during the reaction. Figure 
20 shows that the higher the concentration of NalCU added, the lower the pH value 
was. This shows that there was more methanoic acid produced when the 
concentration of NalCU was increased corresponding to a higher level of oxidation.
Figure 20 -  Change in measured pH with time on the addition of varying concentrations of 
N aI04 to dextran solutions
Dextran solutions that had been oxidised to varying degrees were added to aminated 
polyurethane samples with an equal volume of NaCNBH3 in order to attach the 
polysaccharide to the polymer surface. After washing, SMCs were cultured on the 
surfaces for 3 and 24hrs in serum-containing medium. Figure 21 shows light 
microscope images of methylene blue stained SMCs. After 3 hrs cell attachment was 
poor on all surfaces but was slightly better at the very low and very high NaI04
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concentrations. At this time point cell attachment was least efficient when a 0.14M 
concentration of NaI04 was added. This concentration corresponds to equal masses of 
N aI04 and dextran in the reaction mixture. This trend is the same after 24 hrs. On the 
surfaces with the highest and lowest levels of oxidation, the cells have adhered and 
spread. At intermediate levels of oxidation the cells are mainly still rounded with very 
few having spread at all. Again cell adhesion was at its lowest level when the masses 
of dextran and NaI04 were equal.
Glass
0.047M NaI04
0.094M NaI04
0.14M
0.19M
0.23M
0.28M
Figure 21 - SMC attachment to dextran surfaces produced by oxidising the dextran to different 
extents using varying concentrations of NaI04
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3.2.3 - ELIS As
To assess the efficacy of the protein immobilisation protocol, an ELISA utilising an 
antibody to the section of fibrillin-1 that contains the RGD sequence was carried out. 
The concentration of protein added to the oxidised dextran surfaces was varied from 0 
to 10 (ig/ml. The results show that the attachment of protein increases as the 
concentration added increases (Figure 22). This trend levels off at the highest 
concentrations with the difference between 5 and lOpg/ml not being statistically 
significant (p > 0.01).
A second ELISA was carried out to determine whether or not the RGD sequence 
contained within the fibrillin fragment was available for integrin binding to the 
surface (Figure 23). The level of absorbance due to the amount of RGD increases as 
the concentration of added protein increases. Again, there is no significant difference 
in the amount of RGD present at the 5 and 10 |xg/ml added protein concentrations
(p > 0.01).
To assess the modification with tropoelastin, an ELISA was carried out using an 
antibody to elastin. As the concentration of added tropoelastin increased the amount 
of attached protein increased (Figure 24). The graph shows that the amount of 
attached protein does not increase further when the concentration of TE added is 
doubled from 5 to 10 [xg/ml (p > 0.01).
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Figure 22 -  An ELISA using an antibody to fibrillin-1 showing the change in amount of fibrillin 
present on the surface as the concentration of added fibrillin PF14 increases
Figure 23 -  An ELISA using an antibody to the RGD sequence showing the change in amount of 
RGD present on the surface as the concentration of added fibrillin PF14 increases
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Figure 24 -  An ELISA using an antibody to elastin showing the change in amount of elastin 
present on the surface as the concentration of added tropoelastin increases
74
3.3 -  Integrin Blocking Studies
3.3.1 -  Fibrillin-1
3.3.1.1 -  Soluble Peptides
Figure 25 -  Change in percentage cell attachment to fibrillin PF14-modified surface with an 
increasing concentration of RGD peptide added to the cell suspension prior to seeding (* 
indicates p £ 0.005 compared to no antibody, n=2)
In order to determine whether cell attachment to the fibrillin-modified surface was 
dependent on the RGD sequence, soluble RGD peptide was added to the cell 
suspension prior to seeding. Figure 25 shows that the higher the concentration of 
soluble peptide in the culture medium the lower the degree of cell attachment to the 
surface. A 50% reduction in attachment compared to the control (no antibody) is
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achieved with just 0.5pg/ml of soluble peptide with further decreases at higher
concentrations.
3.3.1.2 -  Anti-integrin Antibodies
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Figure 26 -  Change in percentage attachment of cells to the fibrillin PF14 surface with 
increasing blocking-antibody concentration added to the cell suspension prior to seeding, anti-av 
(A), anti-p, (B), anti-a5 (C) and anti-Pi (D) (* indicates p £ 0.005 compared to 0 antibody, n=2 
except for p3 where n=4)
The contribution of two different integrins to the attachment of cells to the fibrillin- 
modified surface was investigated by adding antibodies to the various integrin sub­
units to the cell suspension prior to seeding. Figure 26 shows the effect of adding
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antibodies to the av, P3, as and Pi integrin sub-units on cell attachment. Each antibody 
reduced the cell attachment to approximately 50% of the control at a concentration of
0.5pg/ml. Further decreases in cell attachment were seen at higher concentrations 
with a reduction to around 20% for the anti-pi antibody.
3.3.2 -  Tropoelastin
0 0.1 0.5 1 5
Antibody Cone (ug/ml)
Figure 27 -  Change in percentage cell attachment to tropoelastin-modified surfaces with an 
increasing concentration of anti-avp3 antibody added to the cell suspension prior to seeding (* 
indicates p < 0.005 compared to 0 antibody)
To determine the contribution of the avP3 integrin to cell attachment to the 
tropoelastin-modified surface an antibody to the integrin was added to the cell 
suspension prior to seeding. Figure 27 shows that cell attachment decreases on the 
addition of the anti-avP3 antibody to the culture medium. Compared to cell attachment
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in the absence of antibody there are approximately 50% fewer cells attached to the 
modified surface in the presence of 5pg/ml of blocking antibody.
3.4 -  Methylene Blue Staining
3.4.1 -  Fibrillin-1
Figure 28 -  Images of SMCs cultured for 3 hrs (A,B), 24 hrs (C,D) and 4 days (E,F) on plain 
polyurethane (A,C,E) and fibrillin PF14-modified polyurethane (B,D,F)
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Images of cells cultured on plain and fibrillin-modified surfaces were obtained in 
order to study their morphology and growth over a 4 day time period. Figure 28 
shows the difference in cell behaviour on the plain polyurethane and the fibrillin-1- 
modified surfaces. In the first 3hrs of culture the cells are in serum-free medium. The 
cells on the plain polyurethane surface are attached but remain rounded with very 
little spreading apparent. In contrast, the cells on the modified surface have attached 
and are well spread. After the first 3hrs the medium was exchanged for serum- 
containing medium. This enabled the cells on the plain surface to spread out more 
however not to the extent of those on the fibrillin-modified surface. These cells are 
extensively spread and an increase in cell number is evident. After 4 days significant 
cell proliferation has dramatically increased the number of cells on the modified 
surface to the extent that cell-cell contacts have caused the cells to align. It can be 
seen that there are a lot less cells on the plain surface.
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3.4.2 - Tropoelastin
Figure 29 -  Images of SMCs cultured for 3 hrs (A,B), 24 hrs (C,D) and 4 days (E,F) on plain 
polyurethane (A,C,E) and tropoelastin-modified polyurethane (B,D,F)
The images shown in Figure 29 are of SMCs cultured on plain and tropoelastin- 
modified polyurethane. As in Figure 28 the cells were cultured in serum-free medium 
for the first 3 hrs. After this time the cells can be seen to be weakly attached to both 
surfaces but neither has encouraged much adhesion or spreading. After 24 hrs the 
cells have spread considerably on both surfaces but little proliferation is evident.
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After 4 days a low level of cell growth can be seen to have occurred. This level is 
similar on both the plain and modified surface.
3.5 -  Cell Spreading
3.5.1 -  Fibrillin-1
SMCs were cultured on plain and modified polyurethane. After 3 hrs the number of 
cells and the total area taken up by them were measured by taking images and 
analysing them using the Image J software. The average area per cell was calculated 
by dividing the total cell area by the number of cells. Figure 30 shows that cells 
cultured on the fibrillin-modified surface are considerably more spread than on the 
plain polyurethane surface (p < 0.005).
Figure 30 -  Average area per cell of SMCs cultured on plain polyurethane and fibrillin-modified 
surfaces for 3 hours ( * p i  0.005)
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Figure 31 shows the level of cell spreading for SMCs cultured on plain and 
tropoelastin-modified polyurethane. The graph shows that the cells cultured on the 
tropoelastin-modified surface spread out significantly less than those on the plain 
polyurethane (p < 0.005).
3.5.2 -  Tropoelastin
Figure 31 -  Average area per cell of SMCs cultured on plain polyurethane and tropoelastin- 
modified surfaces for 3 hours (*p £ 0.005)
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3.6 -  Cell Proliferation Assay
3.6.1 -  Fibrillin-1
70000
60000
1 day 2 days 4 days
■ PU
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Figure 32 -  Change in cell number on plain and fibrillin PF14-modified polyurethane over 4 
days (*p < 0.005 compared to plain polyurethane)
Figure 33 -  Cell number calculated relative to the number of cells attached to each surface at the 
3hr time point
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The number of SMCs on plain and modified polyurethane was estimated by 
quantifying the DNA harvested from the cells at time points up to 4 days. A standard 
curve was then used to convert the data to cell number. Figure 32 shows the change in 
cell number on plain and fibrillin-modified polyurethane over the 4 day time period. 
The number of cells on both surfaces increased at a steady rate over the 4 days. There 
were statistically more cells on the fibrillin than on the plain surface at all time points. 
In order to show changes in the rate of cell proliferation, the cell number relative to 
the number of cells attached at 3hrs was calculated. Figure 33 shows that there were 
approximately 20 times more cells relative to initial attachment on the plain 
polyurethane at 4 days compared to 10 times more on the fibrillin-modified surface. 
The rate of proliferation was seen to be higher on the plain surface than the fibrillin 
surface at all time points.
3.6.2 -  Tropoelastin
3 hrs 1 day 2 days 4 days
Figure 34 -  Change in cell number on plain and tropoelastin-modified polyurethane over 4 days
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Figure 35 - Cell number calculated relative to the number of cells attached to each surface at the 
3hr time point
As can be seen in Figure 34, cells proliferated on both the plain and tropoelastin- 
modified surfaces over the 4 day time period. The cell number was similar on both 
surfaces at all time points. At 4 days it appears that there are more cells on the plain 
surface than the tropoelastin. However, this difference is not statistically significant 
(p > 0.01). Figure 35 shows how the cell number increases relative to the number of 
cells attached at 3hrs. The graph shows that the cells are proliferating at a higher rate 
on the plain polyurethane surface.
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3.7 -  RT-PCR
Levels of gene expression of various proteins were investigated by reverse 
transcriptase RT-PCR. mRNA was harvested from cells cultured on glass, plain 
polyurethane and fibrillin and tropoelastin-modified surfaces at 3, 6 and 24 hrs. 
These levels were then normalised to the housekeeping gene GAPDH.
Laminin is a major constituent of the basement membrane. Its production was 
investigated in order to see if the cells were encouraged to produce this membrane by 
the modified surfaces. At the 3 hr time point there was no difference in the expression 
of laminin mRNA by the cells cultured on plain polyurethane compared to those on 
glass (Figure 36, Image A). The expression then increased at 6 hrs and 24 hrs. Cells 
cultured on the fibrillin-modified surface expressed slightly more laminin at all time 
points compared to glass (Figure 36, Image A). At 3 hrs the cells produced more 
laminin mRNA on the fibrillin than on the plain polyurethane (Figure 36, Image B). 
This level then decreased to below polyurethane levels at 6 hrs and then there was a 
further decrease at 24 hrs. The expression of laminin by cells on the tropoelastin 
surface was higher than on glass and plain polyurethane at 3 and 24 hrs but was lower 
at 6 hrs (Figure 36, Images A and B).
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Figure 36 -  Laminin mRNA levels compared to GAPDH expressed by cells cultured on the plain 
polyurethane, fibrillin and tropoelastin surfaces compared to glass (A), cells cultured on fibrillin 
and tropoelastin surfaces compared to plain polyurethane (B) and the raw mRNA levels from 
cells cultured on the glass, polyurethane, fibrillin and tropoelastin surfaces (C)
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As it is a component of the elastic fibres in the artery wall, the expression of the gene 
for elastin was investigated. The production of elastin mRNA by the cells followed 
almost the same trend as for laminin. At 3 hrs there was no difference in elastin 
mRNA levels produced by cells on the glass or plain polyurethane surfaces (Figure 
37, Images A and B). The expression then increased at 6 and then 24 hrs. mRNA 
levels were slightly higher on the fibrillin-modified surface than on glass at 3 hrs 
(Figure 37, Image A). They then decreased over time reaching a level lower than on 
glass by 24 hrs. Compared to cells cultured on the plain polyurethane cells on the 
fibrillin surface produced more elastin mRNA at 3 hrs with the level decreasing to a 
lower level at 6 hrs with a further decrease at 24 hrs (Figure 37, Image B). On the 
tropoelastin-modified surface expression of elastin mRNA was higher than on glass 
and plain polyurethane at 3 and 24 hrs but lower at 6 hrs (Figure 37, Images A and 
B).
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Figure 37 -  Elastin mRNA levels compared to GAPDH expressed by cells cultured on the plain 
polyurethane, fibrillin and tropoelastin surfaces compared to glass (A), cells cultured on fibrillin 
and tropoelastin surfaces compared to plain polyurethane (B) and the raw mRNA levels from 
cells cultured on the glass, polyurethane, fibrillin and tropoelastin surfaces (C)
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Fibrillin-1 is another important component of elastic fibres. At 3 and 6 hrs there was a 
lower expression of fibrillin-1 on the polyurethane compared to glass (Figure 38, 
Image A). The expression was then similar to glass at 24 hrs. On the fibrillin- 
modified surface the level of mRNA was again lower than on glass and also lower 
than on the plain polyurethane (Figure 38, Images A and B). At 6 hrs expression was 
lower than on glass but higher than on the polyurethane. By 24 hrs the levels of 
fibrillin mRNA on the glass, polyurethane and fibrillin surfaces are in distinguishable 
on the graphs. Compared to cells cultured on both glass and plain polyurethane the 
cells on the tropoelastin surface expressed less mRNA at 3 hrs but more at 6 hrs 
(Figure 38, Images A and B). By 24 hrs as with the fibrillin surface the expression 
was highly similar to the glass and polyurethane. The values of all these changes are 
extremely small with the scale only reaching from -2 x 10'6 to 2 x 10~6.
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Figure 38 -  Fibrillin-1 mRNA levels compared to GAPDH expressed by cells cultured on the 
plain polyurethane, fibrillin and tropoelastin surfaces compared to glass (A), cells cultured on 
fibrillin and tropoelastin surfaces compared to plain polyurethane (B) and the raw mRNA levels 
from cells cultured on the glass, polyurethane, fibrillin and tropoelastin surfaces (C)
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The expression of the gene for fibronectin was investigated as a general indication of 
extracellular matrix synthesis. This is useful as measurement of protein synthesis is 
an important tool in determining the phenotype of SMCs. Cells on the plain 
polyurethane expressed higher levels of fibronectin mRNA at 3 and 24 hrs but lower 
levels at 6 hrs compared to glass (Figure 39, Image A). On the fibrillin-modified 
surface the cells produced less at all time points compared to glass. Compared to 
plain polyurethane the expression was slightly higher at 3 hrs but lower at 6 and 24 
hrs (Figure 39, Image B). Cells on the tropoelastin-modified surface produced more 
fibronectin mRNA at 3 and 6 hrs compared to glass but less at 6 hrs (Figure 39, 
Image A). The level of expression was similar to that of the cells cultured on the 
polyurethane at 3 hrs it was then lower at 6 hrs and higher at 24 hrs (Figure 39, Image 
B).
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Figure 39 -  Fibronectin mRNA levels compared to GAPDH expressed by cells cultured on the 
plain polyurethane, fibrillin and tropoelastin surfaces compared to glass (A), cells cultured on 
fibrillin and tropoelastin surfaces compared to plain polyurethane (B) and the raw mRNA levels 
from cells cultured on the glass, polyurethane, fibrillin and tropoelastin surfaces (C)
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The expression of smooth muscle a-actin (SMA) mRNA was slightly higher on plain 
polyurethane than glass at 6 and 24 hrs but similar at 3 hrs (Figure 40, Image A). In 
contrast the expression was significantly higher at 3hrs on the fibrillin-modified 
surface. Compared to polyurethane the expression of SMA mRNA on the fibrillin 
surface was a lot higher at 3 hrs, slightly lower at 6 hrs and similar at 24 hrs (Figure 
40, Image B). On the tropoelastin SMA gene expression is significantly higher than 
on glass and plain polyurethane at 3 hrs (Figure 40, Images A and B). These levels 
then decreased to nearly the same as those of glass at 6 and 24 hrs. Expression was 
lower than on polyurethane at 6 hrs but similar at 24 hrs. It should be taken into 
account that the scale of these variations is a great deal larger than the other graphs in 
this section.
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Figure 40 -  Smooth muscle a-actin mRNA levels compared to GAPDH expressed by cells 
cultured on the plain polyurethane, fibrillin and tropoelastin surfaces compared to glass (A), 
cells cultured on fibrillin and tropoelastin surfaces compared to plain polyurethane (B) and the 
raw mRNA levels from cells cultured on the glass, polyurethane, fibrillin and tropoelastin 
surfaces (C)
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On plain polyurethane smoothelin mRNA expression was similar to glass at 3 hrs and 
then increased up to a high level of expression at 24 hrs (Figure 41, Image A). On the 
fibrillin-modified surface smoothelin gene expression was higher than on glass and 
polyurethane at 3 and 6 hrs but then lower at 24 hrs (Figure 41, Images A and B). 
Cells cultured on the tropoelastin produced more smoothelin mRNA than those on 
glass and polyurethane at 3 hrs but less at 6 hrs (Figure 41, Images A and B). 
Expression on tropoelastin was higher compared to glass at 24 hrs but lower 
compared to polyurethane.
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Figure 41 -  Smoothelin mRNA levels compared to GAPDH expressed by cells cultured on the 
plain polyurethane, fibrillin and tropoelastin surfaces compared to glass (A), cells cultured on 
fibrillin and tropoelastin surfaces compared to plain polyurethane (B) and the raw mRNA levels 
from cells cultured on the glass, polyurethane, fibrillin and tropoelastin surfaces (C)
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3.8 -  Immunostaining
3.8.1 -  Cell-matrix Adhesions
The amount and distribution of various integrins was investigated by staining for the 
a s  and pi sub-units and the avP3 integrin. Figure 43 shows the presence of the (X5 sub­
unit on all cells. It can be seen around the nucleus of the cells cultured on all of the 
surfaces. The cells grown on the modified surfaces have a more organised distribution 
of the sub-unit. It is highly concentrated at the periphery and is apparent in the many 
filopodia extending out from the cells. Similar results can be seen in Figure 44 where 
the green stain represents the Pi integrin sub-unit. There is a high concentration of 
stain around the cell nuclei on all surfaces. On the glass, fibrillin and tropoelastin 
surfaces elongated structures can be seen to extend out from this area of high 
concentration. These are not as evident on the plain polyurethane surface.
Figure 45 shows positive staining for the integrin 0^ 3. In contrast to the as and Pi 
sub-units this integrin is not seen at a high concentration around the nucleus. The 
cells cultured on the glass and plain polyurethane surfaces show a diffuse distribution 
of the integrin with brighter areas of staining at the edges of the cells. Cells on the 
modified surfaces exhibit strong staining along the cell periphery and extensive 
filaments are visible leading out from the cells. These filaments are particularly clear 
on the tropoelastin surface where they extend over a large area around the cell body.
Cells cultured on each surface were also stained for vinculin. This is a molecule 
found in focal contacts. If the staining was positive then short lines would be seen
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aligned at the edges of the cells. Figure 46 shows a lack of any structures resembling 
these on the cells on all of the surfaces. Any staining is highly diffuse and the 
fluorescence could easily be due to non-specific binding of the primary antibody. 
Figure 42 shows a control image where the same staining protocol was used but the 
primary antibody was excluded. The image shows a low level of green fluorescence 
in the area of the cell cytoplasm. This represents non-specific binding of the 
AlexaFluor488 secondary antibody.
Figure 42 -  SMCs stained using the protocol followed for all of the immunofluorescence tests but 
with the primary antibody excluded
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Figure 43 -  SMCs stained for integrin as after 2 days cultured on glass (A), PU (B), fibrillin PF14 
(C) and tropoelastin (D) (Scale bars = 20pm)
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Figure 44 - SMCs stained for integrin Pi after 2 days cultured on glass (A), PU (B), fibrillin PF14 
(C) and tropoelastin (D) (Scale bars = 10pm apart from image A which is 20pm)
Figure 45 - SMCs stained for integrin avp3 after 2 days cultured on glass (A), PU (B), fibrillin 
PF14 (C) and tropoelastin (D) (Scale bars = 20pm)
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Figure 46 - SMCs stained for vinculin after 2 days cultured on glass (A), PU (B), fibrillin PF14 
(C) and tropoelastin (D) (Scale bars = 20pm)
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3.8.2 -  Extracellular Matrix Proteins
The production of extracellular matrix proteins by cells cultured on the surfaces was 
investigated. The presence of laminin was found in the cells on all 4 surfaces. After 2 
days bright green staining can be seen in the cytoplasm of each cell mostly around the 
nucleus (Figure 47). After 4 days the laminin is evident throughout the cells.
Figure 48 shows the presence of collagen IV in the cytoplasm of the cells cultured on 
all 4 surfaces. The amount of collagen is fairly low at both time points. It is evenly 
distributed throughout the cells with a speckled appearance.
The synthesis of fibulin-5 by the cells can be seen in Figure 49. After 2 days the 
protein can be seen mainly around the edge of the cells. After 4 days there appears to 
be a higher concentration in the cells cultured on the modified surfaces compared to 
the glass and plain polyurethane.
Figure 50 shows a high concentration of tropoelastin in the cells cultured on glass, 
plain polyurethane and fibrillin PF14. The staining is brightest around the nuclei but 
is present throughout the cells' cytoplasm.
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Figure 47 -  SMCs stained for laminin after being cultured on glass (A,B), PU (C,D), fibrillin 
PF14 (E,F) and tropoelastin (G,H) for 2 days (A,C,E,G) and 4days (B,D,F,H) (Scale bars = 
20pm)
Figure 48 - SMCs stained for collagen IV after being cultured on glass (A,B)» PU (C,D), fibrillin 
PF14 (E,F) and tropoelastin (G,H) for 2 days (A,C,E,G) and 4 days (B,D,F,H) (Scale bars = 
20(xm)
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Figure 49 - SMCs stained for fibulin-5 after being cultured on glass (A3)> PU (C 3)> fibrillin 
PF14 (E,F) and tropoelastin (G,H) for 2 days (A ,C ,E > C J) and 4 days (B,D*F>H) (Scale bars = 
20(tm)
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Figure 50 - SMCs stained for tropoelastin after being cultured on glass (A,B)> PU (C,D) and 
fibrillin PF14 (E,F) for 2 days (A,C,E) and 4 days (B,D,F) (Scale bars = 20pm)
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3.8.3 -  Phenotypic Markers
Cells were stained for the SMC phenotype specific marker a-smooth muscle actin. 
Figure 51 shows the appearance of the cells after 4 days. Images A and B both show 
cells cultured on glass. Image A shows a cell with distinct actin fibres whereas image 
B shows both a cell with fibres and one without. The variation in these images is due 
to the high level of confluence of the cells after 4 days. The cell in image A and one 
of the cells in image B are growing on top of other cells whereas the cells in the other 
images are growing directly on the surfaces. The cells attached to the other surfaces 
show a diffuse pattern of smooth muscle actin and a clear lack of organised stress 
fibres.
Cells were also stained for smoothelin. This is a marker of the contractile phenotype 
of SMCs. Figure 52 shows that no cells stained positive for this protein on any 
surface.
Smooth muscle cells cultured on the surfaces were also stained for calponin and 
caldesmon. No cells stained positive for these proteins on any surface at either time 
point.
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Figure 51 -  SMCs stained for a-smooth muscle actin after being cultured for 4 days on glass 
(A,B), PU (C), fibrillin PF14 (D) and tropoelastin (E) (Scale bars = 20pm)
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Figure 52 - SMCs stained for smoothelin after being cultured for 4 days on glass (A), PU (B), 
fibrillin PF14 (C) and tropoelastin (D) (Scale bars = 20pm)
3.9 -  Western Blot Analysis
M G  G PU PU 
38.5 k D a ^ * “
F F T E  T E
A
B
Figure 53 -  Western blot gel images obtained from protein samples taken from SMCs cultured 
on glass (G), polyurethane (PU), fibrillin-modified polyurethane (F) and tropoelastin-modified 
polyurethane (TE) for 2 (A) and 4 (B) days. Samples were run against a molecular weight 
marker (M)
Levels of various proteins synthesised by cells cultured on glass, plain polyurethane 
and the modified surfaces were quantified using Western blotting. The gel images in 
Figure 53 show analysis of GAPDH production by cells cultured on glass (G), plain 
polyurethane (PU), fibrillin-1 PF14 (F) and tropoelastin (TE) after 2 and 4 days. Two 
repeats are shown for each surface. The production of laminin, collagen IV, fibrillin- 
1, tropoelastin, smooth muscle a-actin, smoothelin, calponin and caldesmon were also 
investigated, however there were no bands visible on the gels after processing.
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Chapter 4 - Discussion
4.1 -  Surface Modification
The initial functionalisation of the polyurethane was achieved by using a reversible 
swelling technique to incorporate polyethyleneimine (PEI) into the surface layer. This 
technique has been used to trap polyethylene oxide) and other water soluble 
polymers in the surface of scaffolds.69'72,190 In previous work using a different 
polyurethane, the aminating solution consisted of 82% DMAc, 14.5% H2O and 3.5% 
PEI.187 In other unpublished work it was found that a similar degree of amination 
could be achieved on the b9 polyurethane used in this project by using a 1:1 ratio of 
DMAc to H20  and 3.5% PEI. Using a lower amount of solvent is beneficial in that 
less of the polymer will be lost into solution. After the aminating treatment the 
presence of amine groups on the surface was verified using a solution of 
fluorescamine. This is a molecule that fluoresces on reaction with a primary amine. 
Figure 18 shows a higher level of fluorescence emitted from the aminated surface 
than the plain polyurethane surface (p < 0.005) indicating that there were a large 
number of primary amines present.
Dextran is a polysaccharide that has previously been shown to prevent protein 
adsorption and cell adhesion to surfaces to which it is attached.48,191'192 The 
polysaccharide acts in a similar way to poly(ethylene glycol). It has highly hydrated,
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randomly oriented chains, providing that it is pinned to the surface at a small number 
of points. Protein adsorption would compress the chains and restrict their motion 
therefore causing an unfavourable change in entropy.193 Partially oxidised dextran 
was attached to the aminated polymer surface using a reductive amination reaction. 
The efficacy of this attachment was investigated using a dextran-FITC conjugate. 
This was partially oxidised and attached to the aminated surface in the same way as 
the un-conjugated dextran. To form a non-oxidised control, distilled water was added 
to the dextran in place of the NaIC>4 solution. Figure 19 confirms that only the 
oxidised dextran covalently attached to the aminated surface. The non-oxidised form 
was washed away as can be seen by the decrease in fluorescence with number of 
washes.
It is important that the properties of dextran that prevent protein adsorption and cell 
adhesion are not diminished by the immobilisation process. The polysaccharide needs 
to be oxidised enough to ensure adequate attachment. However, if too many reactive 
aldehyde groups are produced by the oxidation the dextran will be attached to the 
surface at so many points that the chains will be unable to hydrate and move 
sufficiently to prevent the adsorption of proteins. In order to determine the optimum 
level of oxidation, different concentrations of NaIC>4 were added to solutions of 
dextran and the pH of the solutions monitored over 24hrs. Figure 20 shows that the 
higher the concentration of NaI04 added to the dextran the lower the pH level 
reached. The drop in pH was due to the release of methanoic acid during the 
oxidation reaction. It therefore follows that the lower the pH the more aldehyde 
groups will be present on the dextran. Each of the solutions of oxidised dextran was
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then added to aminated polyurethane surfaces with an equal volume of NaCNBH3 
and left overnight on a mechanical shaker. After washing, smooth muscle cells were 
cultured on each of the surfaces and images taken of them after 3 and 24 hrs. It is 
clear from Figure 21 that fewer cells appear to have adhered to the surface produced 
by the attachment of dextran oxidised by the 0.14M solution corresponding to an 
equal mass of N aI04. At low levels of oxidation it is likely that there weren't enough 
aldehyde groups formed to enable sufficient attachment of dextran to the surface. The 
polysaccharide would be removed during the washing step. This explains why cell 
attachment has not been discouraged. At the highest levels of oxidation there would 
be a large number of aldehydes and therefore the dextran would be attached to the 
surface at many points restricting its motion to the point where it is incapable of 
preventing cell attachment. It is also possible that at the highest NaI04 concentrations 
the majority of the monomeric units would undergo oxidation. This would completely 
disrupt the polysaccharide structure rendering it ineffective. Consequently an 
intermediate level of oxidation is necessary to ensure the effects of the dextran are 
optimised.
Further oxidation of the attached dextran layer with a dilute solution of NaI04 
produced more aldehydes to which the proteins could be attached, again using a 
reductive animation reaction. The coupling occurs via amine groups present at the N- 
terminal of the protein or via lysine side chains. The ELISA that was carried out 
using the anti-fibrillin antibody confirmed the presence of the fibrillin fragment on 
the surface. Figure 22 shows that the higher the concentration of protein added to the 
oxidised dextran surface the higher the level of attachment was. This trend levels off
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at higher concentrations of added protein. Doubling the concentration from 5p.g/ml to 
10p,g/ml only gave a slight increase in protein attachment indicating that the surface 
was close to saturation and that were are no remaining aldehydes available for 
binding.
By using an anti-RGD antibody, the second ELISA showed that the RGD sequence 
was exposed on the protein surface and not concealed due to conformational 
restraints. This shows that the process of attaching the protein does not alter its 
conformation to the extent that the cell binding motif is unavailable for cell binding. 
The increase in the amount of RGD correlated with the increased concentration of 
protein added to the surface. Again this trend levelled off at the higher concentrations 
substantiating the idea that the surface was close to saturation at the 5p.g/ml point 
(Figure 23).
ELISA assessment of the tropoelastin-modified surface using an anti-elastin antibody 
verified the presence of the protein. As in the case of the fibrillin fragment, an 
increase in the concentration of added protein resulted in an increase in the level of 
attachment. Figure 24 shows that an increase in tropoelastin concentration from 
5|j,g/ml to lOpg/ml produced no increase in attachment. This suggests that the surface 
was saturated with protein when a concentration of 5[rg/ml was used.
As the surfaces appeared to be saturated with protein when a concentration of 5p,g/ml 
was used, this is the concentration that was used in all subsequent cell culture studies.
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4.2 -  Integrili Blocking Studies
Integrins are cell surface receptors that bind to extracellular matrix proteins 
(ECM).194 They consist of two sub-units, an a  chain and a p chain. In mammals 19 
different a  chains and 8 different p chains have been identified, these combine to 
make approximately 24 different integrins. They are transmembrane proteins that link 
the extracellular matrix to the cytoskeleton of the cell via various adapter proteins 
such as talin. Different integrins bind to different ECM ligands. The binding of an 
integrin to a ligand triggers intracellular signalling events that control functions such 
as cell migration, proliferation or differentiation.195'200
As mentioned in section 1.1.3.2.2, the amino acid sequence arginine-glycine-aspartic 
acid (RGD) has been shown to be a high affinity ligand for a number of cell-surface 
integrins. In this work an RGD-containing fragment of fibrillin-1 was covalently 
attached to a polyurethane surface. The mechanism of cell attachment to the modified 
surface was investigated. In order to determine the RGD-dependence of the 
attachment, the soluble peptide GRGDSPK was added to the cell suspension prior to 
seeding. This would bind to any integrins that recognise the RGD sequence therefore 
preventing them from binding to the protein on the surface. Figure 25 shows that cell 
attachment was diminished when the peptide was present in the cell suspension. This 
shows that cells bind to fibrillin-1 via the RGD motif. Increasing concentrations of 
added peptide caused further decreases in cell attachment by blocking increasing 
numbers of integrins. Percentage attachment compared to the control declined to 
around 20% at 10|xg/ml indicating that cell attachment to the modified surface was
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predominantly via the RGD motif contained within the protein. These results agree 
with previous work carried out on RGD-containing fibrillin-1 fragments adsorbed on 
to tissue culture plastic.148,151
These results also show that the RGD sequence was available at the protein surface 
and not concealed due to conformational restraints imposed by the surface 
modification procedure. By reacting the amino groups of the protein with the 
aldehyde groups on the surface it is possible that the intramolecular forces that 
control the protein conformation could be disrupted therefore altering the natural 
stmcture of the protein. As mentioned in the introduction, altering the conformation 
by just a tiny amount can alter the cell-binding properties of a protein. As similar 
results were obtained for the adsorbed and covalently attached protein it is clear that 
the modification protocol does not adversely affect the protein structure.
Various antibodies specific to certain integrins were utilised in order to determine 
which integrins were involved in SMC attachment to the fibrillin-modified surface 
(Figure 26). Each antibody was added to the cell suspension prior to seeding. The 
antibody would bind to the specific integrin preventing it from attaching to the 
fibrillin on the surface. Both the anti-av and the anti-p3 antibodies caused a reduction 
in the number of cells attached to the modified surface after 1 hr compared to cells in 
the absence of any antibody. The anti-av antibody caused a reduction in cell 
attachment in a dose dependent manner with a decrease to approximately 35% at a 
5pg/ml concentration of antibody. The anti-p3 antibody caused a decrease to 
approximately 50% at all concentrations. This indicates that all of the p3 integrin sub­
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units may have been blocked at low antibody concentrations and so higher 
concentrations will have no additional effect. These results show that the a vP3 integrin 
is involved in SMC attachment to the fibrillin-modified surface. Previous work has 
been carried out investigating cell attachment to fibrillin-1 PF14 adsorbed to tissue 
culture plastic148,151 The results of that study agree with the results presented here and 
show that the 0^3 integrin was involved in mediating cell attachment to the protein 
fragment.
The investigation into cell attachment to adsorbed fibrillin-1 PF14 also showed that 
the a5Pi integrin was important. The a5 sub-unit was blocked with an antibody prior 
to cell seeding. The results showed a higher decrease in cell attachment than when the 
ttvPs integrin was blocked. To determine whether or not cell attachment to covalently 
bound PF14 was also mediated by the a5Pi integrin, antibodies to the a5 and Pi sub­
units were added to the cell suspension prior to seeding. It can be seen in Figure 26 
that cell attachment was inhibited to a great extent by both of these antibodies with 
levels reaching approximately 20% of the control at 5(ig/ml. It is clear that cell 
attachment to covalently attached PF14 was mediated by both the avp3 and the a5Pi 
integrin but with the latter playing the most significant role. These results agree with 
the previous study on adsorbed PF14 and so it can be said that the covalent 
attachment procedure does not adversely alter the cell-binding properties of the 
protein.
It has previously been shown that for efficient cell attachment to both fibronectin and 
fibrillin-1 via the a5Pi integrin a synergy site upstream of the RGD sequence is
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necessary.151,201'203 This site is thought to physically stabilise the binding between the 
integrin and the RGD motif. The PF14 fragment of fibrillin-1 has been identified as 
containing the synergy site. It is found within the 4 cbEGF-like domains upstream of 
the RGD motif. As it has been shown here in Figure 26 that the a5Pi integrin is highly 
involved in the cell attachment to the PF14-modified surface it is clear that this 
synergy site is available on the surface in addition to the RGD sequence. This 
provides further evidence that the surface modification protocol does not change the 
protein conformation to any great extent.
Integrin-specific antibodies were used to investigate the mechanism of cell 
attachment to the tropoelastin-modified surface. In this instance an antibody to the 
a vP3 integrin was used (LM609). The antibodies to the separate integrin sub-units 
were not used in this case due to the limited availability of the tropoelastin. Figure 27 
shows a dose dependent decrease in cell attachment on the addition of the antibody to 
the cell suspension prior to seeding. Attachment was reduced by 50% at an antibody 
concentration of 5pg/ml. These results indicate that the avP3 integrin was involved in 
mediating cell attachment to the tropoelastin-modified surface. It should be noted that 
this particular experiment could only be carried out once, again due to the limited 
supply of tropoelastin. Previous work carried out on adsorbed tropoelastin has shown 
that there is an interaction between the avp3 integrin and an amino acid sequence 
located near to the C-terminus of tropoelastin.167 The results presented here show that 
this interaction still occurs when the protein is covalently attached using this surface 
modification protocol. •
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The particular integrins that bind to proteins are of interest as they are responsible for 
triggering the intracellular signalling events that control the behaviour of the cell. As 
different integrins bind to different ligands, these signalling events will vary 
depending on the protein that the cell is in contact with. It is therefore possible that 
cell behaviour could be controlled by exposing the cells to a specific protein-covered 
surface. In this work the involvement of the avP3 integrin in cell attachment to both 
the fibrillin and tropoelastin surfaces has been shown. In addition to this, attachment 
to the fibrillin-modified surface was also seen to be mediated by the a5pi integrin. 
The subsequent behaviour of cells cultured on the modified surfaces will be discussed 
in the following sections however specific relationships between the different 
integrins and the intracellular signalling pathways have not been established during 
this project.
4.3 -  Methylene Blue Staining
Smooth muscle cells were seeded on to plain and fibrillin PF14-modified 
polyurethane surfaces in serum-free medium. They were cultured for 3 hrs and then 
washed, fixed and stained with methylene blue. This is a stain that, at neutral pH, 
dyes the entire cell blue. It is evident from Figure 28 that the cells on the plain 
polyurethane surface did not adhere well. They attached only enough to prevent them 
being washed away in the staining procedure. There was no sign of the cells 
spreading out. This is due to a lack of protein for the cell surface integrins to bind to. 
The cells were unable to form focal adhesions and so remained rounded. In contrast
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to this, cells on the fibrillin-modified surface attached and started to spread. The 
protein fragment on the surface allows for integrin binding and subsequent focal 
adhesion formation. This in turn enabled the cells to spread and adhere strongly to the 
surface.
Cells were also cultured on the surfaces for 24 hrs and 4 days. Again the cells were 
grown in serum-free medium for the first 3 hrs. However, after this time SMGS- 
containing medium was added to each well. Images C and D in Figure 28 show the 
cells' appearance after 24 hrs in culture. Cells on the plain polyurethane have now 
started to spread out. This was possible due to the adsorption of serum-proteins on to 
the surface from the growth supplement that was added at 3 hrs. The cells now have 
ligands for their integrins to bind to and so can form focal adhesions that enable the 
cells to spread out. Cells on the fibrillin-modified surface have spread out even more 
extensively. After 4 days a degree of proliferation has occurred on both surfaces. 
Cells on the plain polyurethane are well spread and the cell number is much higher 
than at 24 hrs. Cells on the fibrillin have proliferated to such an extent that cell-cell 
contact has caused them to align.
SMCs in vivo have a quiescent, contractile phenotype and a bipolar morphology. 
They do not proliferate or synthesise much extracellular matrix. In contrast, when the 
blood vessel is injured the disruption of the basement membrane causes a phenotypic 
transformation.204 The cells become proliferative, start synthesising extracellular 
matrix and adopt a fibroblast-like morphology.172'175,205 As mentioned in section 
1.2.4, SMCs harvested from blood vessels and cultured in vitro also undergo this
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phenotypic change, their morphology and proliferative capacity change rapidly in the 
unnatural environment.
In the images in Figure 28 the SMCs have a fibroblast-like morphology and are able 
to proliferate. It is clear that the cells cultured on both the plain and modified surfaces 
had a synthetic phenotype rather than a contractile one. The protein-modified surface 
was unable to maintain the cells in their in vivo phenotype even though fibrillin is a 
natural component of the artery wall. This is not unexpected as the fibrillin fragment 
contains cell-binding sequences similar to fibronectin and vitronectin. SMCs cultured 
on both of these proteins have been shown to rapidly adopt a synthetic 
phenotype.3,129,206,207 It has also been shown that freshly isolated SMCs cultured on 
surface-immobilised GRGDSC peptide undergo a phenotypic transformation from 
contractile to synthetic.208 It is therefore possible that binding of integrins to the RGD 
sequence triggers an intracellular signalling pathway that results in this modulation of 
SMC phenotype.
In the context of an artificial vascular graft, the proliferation of the SMCs would be 
necessary to form a confluent layer on to which endothelial cells could be seeded. 
However, this growth would need to be controlled to prevent vessel occlusion. The 
attachment of the fibrillin fragment alone would not be suitable as a surface 
modification. Other methods would need to be employed in order to gain the required 
level of control over the cells.
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Separately, cells were seeded on to plain and tropoelastin-modified polyurethane. 
They were then stained with methylene blue at 3 hrs, 24 hrs and 4 days. As before, 
the cells were cultured in the absence of serum for the first 3 hrs. After this time cells 
on both surfaces had started to attach but very little spreading was evident (Figure 
29). The appearance of the cells was similar on both the plain and modified surfaces. 
The lack of cell spreading on the polyurethane is likely due to the lack of protein 
ligands available for the cell-surface integrins to bind to. The presence of the 
tropoelastin on the modified surface would provide many potential ligands available 
to the cells. However, it is clear that these particular areas of the protein do not 
encourage cell adhesion to any great extent. After 24 hrs the cells on both surfaces 
were well spread. As before this is most likely due to the serum proteins adsorbed on 
to the surface from the SMGS-containing culture medium added after the first 3 hrs. 
It is also possible that cells on the tropoelastin needed more time to start spreading. 
The quality of the attachment at 3 hrs may not have been adequate for the cells to 
form strong focal adhesions. The extra time up to 24 hrs could have been necessary 
for these adhesions to form to allow the cells to adhere strongly and spread out. It is 
also possible that growth factors present in the SMGS-containing medium 
encouraged the cells to spread. To elucidate the reason for the poor spreading on the 
tropoelastin surface it would be necessary to culture the cells in the absence of serum 
for a slightly longer time period. Images E and F in Figure 29 show the cells after 4 
days in culture. A small increase in cell number can be seen on both surfaces but it is 
clear that cell proliferation has not been encouraged by either surface.
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The SMCs had a fibroblast-like morphology from 24 hrs onwards. Although their rate 
of proliferation was low it was clear that they had adopted a synthetic phenotype 
rather than a contractile one as on the fibrillin-modified surface. If the cell attachment 
that occurred was due to adsorbed serum proteins then it is likely that cell-surface 
integrins had bound to the RGD sequences present in the fibronectin and vitronectin. 
As discussed in section 4.3.1, binding to an RGD motif may trigger an intracellular 
signalling pathway that results in a synthetic phenotype being achieved.
The effects of the two proteins on the behaviour of the cells were very different. The 
fibrillin fragment allowed cells to attach and spread, even in the absence of serum. 
Conversely, cells on the tropoelastin didn't start to spread until after the 3 hr time 
point. Whether this was due to the addition of serum or to inadequate adhesion at this 
time is not clear. The difference in growth rate is unlikely to be due to the cells on the 
tropoelastin having a more contractile phenotype than those on the fibrillin as the 
morphology of the cells appears the same. It is more likely to be due to less efficient 
binding of the cells to the tropoelastin.
4.4 -  Cell Spreading
When cells first attach to a surface they are rounded. The cells produce filopodia that 
then bind to the surface via integrins if suitable protein ligands are available. The 
bound integrins then cluster together followed by the formation of focal adhesions. 
These in turn cause organisation of the cytoskeleton that they are attached to and then
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extension of the cell membrane. In order for cells to spread significantly efficient 
binding of the integrins to the extracellular matrix is necessary.
In this study the degree of cell spreading was estimated using image analysis. SMCs 
were cultured on the plain and modified surfaces for 3 hrs in serum-free medium. The 
cells were then fixed and stained with methylene blue. Images of the cells were taken 
using a digital camera attached to a light microscope. The number of cells in each 
field of view was counted and the total area taken up by cells was determined. The 
degree of cell spreading was calculated as the area divided by the cell number. This 
technique only gives an estimate of the average degree of spreading due to the 
sensitivity of the image analysis software. The areas at which the cells are most 
spread appear almost transparent and so are not recognised by the programme. To 
reduce the error caused by this, gaps within the cells were filled in, first by the 
software and then manually. This meant that a more complete cell image would be 
measured. A large number of images were analysed to reduce the error as much as 
possible and a number of sample repeats were used.
There was a highly significant difference in the level of spreading of the cells on the 
plain polyurethane compared to those on the fibrillin-modified surface (Figure 30). 
Cells seeded on to the modified surface had an average area per cell of around 
720pm2 whereas cells on the plain surface only reached around 160pm2. The cells 
were unable to form adequate focal contacts on the plain polyurethane and so are 
unable to spread. It is clear that the cells on the fibrillin-modified surface had 
successfully formed strong focal contacts and these allowed the necessary
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cytoskeletal organisation to take place for the cells to spread. The strength of these 
contacts is the result of strong binding of cell-surface integrins to various amino acid 
sequences found on the surface of the protein, including the RGD motif. Even though 
there are errors associated with this method of measuring the degree of spreading of 
the cells the results can be taken to be fairly accurate as they are backed up by the 
images in Figure 28. The images of the cells cultured on the surfaces for 3 hrs in 
serum-free medium show rounded cells on the plain polyurethane and well-spread 
cells on the fibrillin-modified surface.
Cells cultured on the tropoelastin surface did not spread well. They were even less 
spread out than on the plain polyurethane (Figure 31). It is clear that the tropoelastin 
on the surface did not encourage focal contact formation and so the cells were unable 
to organise their cytoskeleton in order to spread. The images in Figure 29 show the 
cells after 3 hrs in serum-free medium. These cells were rounded and not at all spread 
out, which agrees with the quantitative data. As mentioned in section 4.5.2 it is 
possible that cell attachment to the tropoelastin surface may be weak at the 3 hr time 
point and more time may be needed to form adequate focal adhesions.
The fibrillin and tropoelastin surfaces have very different effects on the behaviour of 
the smooth muscle cells. The fibrillin-modified surface caused the cells to spread out 
extensively in the 3 hr time period whereas on the tropoelastin-modified surface the 
cells remained rounded. These quantitative results are supported by the images in 
Figure 28 and Figure 29. The presence of cell binding sequences on the fibrillin 
surface enabled the SMCs to form strong focal contacts. Any cell-binding sequences
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on the tropoelastin surface only formed weak interactions after 3 hrs and therefore the 
cells were unable to spread.
4.5 -  Cell Proliferation
In order for SMCs to proliferate they need to be attached and spread out on the 
surface on which they are cultured. There are two main reasons for this. The first is 
the flattened shape of the cell. The more spread the cell is, the greater proportion of 
growth factor receptors are available on its surface. It has been shown that the height 
of a cell is inversely proportional to the amount of DNA synthesis that occurs in the 
cell cycle.209 The second reason for the dependence of the cells on anchorage to a 
surface is the need for integrin engagement. The integrins bind to the ECM and 
become clustered. They then associate with a signal transduction complex that 
initiates actin filament formation and cytoskeletal organisation. Integnn association 
with this signal transduction complex causes phosphorylation of various protein 
tyrosine kinases such as focal adhesion kinase (FAK). This activates a series of 
events that leads to DNA replication and cell division.210,211 Without this integrin 
initiated signalling cascade cells are unable to undergo mitosis.
There is increasing evidence that integrins and growth factor receptors have a 
synergistic relationship. The binding of growth factors to their relevant receptors and 
the binding of integrins to the ECM are both required for the cell cycle to 
progress.196,197'199,212 Various integrins have been shown to associate with growth
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factor receptors and subsequently activate them. The avP3 integrin has been co- 
immunoprecipitated with the PDGF receptor and the Pi integrin sub-unit has been co-
200 213immunoprecipitated with the EGF receptor. ’
This shows that in order for cell proliferation to occur it is necessary for the cells to 
attach to the ECM via their integrins and subsequently spread out to maximise the 
number of growth factor receptors available for binding.
The proliferation of the SMCs cultured on plain and modified surfaces was assessed 
by estimating the cell number using DNA quantification. Cells were cultured in 
serum-free medium for the first 3 hrs. At this time point there were approximately 4 
times more cells present on the fibrillin PF14 surface than on the plain polyurethane 
(Figure 32). This quantitative result agrees with the images taken of methylene blue 
stained cells after 3 hrs (Figure 28). The initial attachment of the cells was more 
efficient on the modified surface due to the presence of integrin-binding amino acid 
sequences present on the protein. The plain polyurethane had no protein due to the 
lack of serum in the culture medium and so cell attachment is very poor.
After the initial 3 hrs of culture the medium was replaced with SMGS-containing 
medium. The DNA was then quantified at the 1 day time point. The average number 
of cells had increased on both surfaces. As mentioned at the start of section 4, for cell 
growth to occur it is necessary for the cells to be attached to the surface via integrins 
and for the cell to be well spread. By again referring to the images in Figure 28 it can 
be seen that cells on both the plain and modified surfaces are well spread and so able
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to proliferate. The spreading of cells on the plain polyurethane is possible due to 
adsorption of serum proteins from the culture medium. The cells can attach to these 
proteins via their integrins and therefore spread out and proliferate. There were more 
cells on the fibrillin surface than the plain surface as was seen at 3 hrs. However, the 
rate of proliferation of the cells on the plain surface was higher than on the modified 
surface (Figure 33). After 1 day there were only 2.5 times more cells on the fibrillin 
compared to 4 times more at 3 hrs. This could be due to the limited amount of growth 
factors and nutrients available in the medium. The greater number of cells on the 
fibrillin samples would use up the growth factors and nutrients a lot faster than the 
limited number of cells on the plain surface. These would have an excess and so be 
able to proliferate at a higher rate.
At the 2 day time point a higher rate of proliferation on the plain surface was again 
evident. This can be seen by comparing the cell number to the number of cells 
attached at the 3hr time point (Figure 33). By 4 days the cells were proliferating at a 
even higher rate on the plain polyurethane surface. The lower proliferation rate on the 
modified surface is again likely due to nutrient availability. As can be seen from the 
methylene blue images in Figure 28 the cells were almost confluent at 4 days on the 
fibrillin-modified surface and the quantitative data in Figure 32 shows that there were 
almost twice as many cells on this surface than on the plain polyurethane. This 
dramatic difference in cell number would result in a large difference in growth factor 
and nutrient availability. Another reason for the lower proliferation rate on the 
fibrillin is the change in cell shape caused by cell-cell contacts at this level of 
confluency. At this point the cells had become aligned and bi-polar. They were a lot
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less well spread and so will have fewer growth factor receptors available for binding. 
This would reduce their rate of cell division.
It is clear that the fibrillin greatly enhanced the attachment and spreading of the cells 
in the absence of serum proteins. However, the cells were able to attach just as well to 
adsorbed serum when it is added. Two of the main serum proteins are fibronectin and 
vitronectin. Both of these contain RGD motifs as in the fibrillin fragment. These 
enable the cells to bind to the plain surface via their integrins and form strong focal 
adhesions. There doesn't appear to be any effect on the rate of cell proliferation by the 
fibrillin.
After 3 hrs in serum-free medium there were 1.7 times more cells attached to the 
tropoelastin surface than the plain polyurethane (Figure 34). The addition of SMGS- 
containing medium at this time did not encourage any cell proliferation on the 
tropoelastin surface but the number of cells on the plain surface doubled in the 24 hr 
time period. This put the cell number as almost identical after 1 day of culture. By 
referring to the images in Figure 29 it can be seen that the cells are still rounded after 
3 hrs but have spread considerably by 24 hrs. This lack of spreading explains why the 
cells were unable to proliferate. They had not formed adequate focal adhesions and so 
could not initiate signal transduction in order to progress the cell cycle to the mitosis 
stage.
At 2 days there was a slight increase in cell number, this appeared greater on the 
tropoelastin but the difference between the surfaces was not statistically significant.
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The rate of proliferation between 2 and 4 days was fairly high with the cell number 
increasing by 2.7 and 1.9 times in that period on the plain and tropoelastin-modified 
surfaces respectively. The rate of proliferation on the plain surface was much higher 
by the 4 day time point (Figure 35). The cells were well attached to the serum 
protein-coated plain polyurethane and so were able to proliferate extensively. 
Conversely, cells on the tropoelastin-modified surface were less able to grow, 
possibly due to less efficient adhesion.
These results show further evidence that the fibrillin and tropoelastin surfaces have 
very different effects on the behaviour of the SMCs. The fibrillin-modified surface 
caused the cells to proliferate extensively whereas the tropoelastin did not support 
any cell growth until SMGS-containing medium was added. These quantitative 
results are again supported by the images in Figure 28 and Figure 29. The presence of 
cell binding sequences on the fibrillin surface enabled the SMCs to form strong focal 
contacts and trigger signalling pathways that caused the cells to divide. Any cell­
binding sequences on the tropoelastin surface only formed weak interactions and 
therefore the cells were unable to trigger the intracellular signalling pathways 
necessary for cell proliferation.
4.6 -  RT-PCR
RNA was harvested from SMCs cultured on plain and modified polyurethane for 3 
hrs, 6 hrs and 24 hrs. The mRNA was reverse transcribed to synthesise cDNA. This
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was then analysed using PCR to determine whether or not the surfaces had an effect 
on the expression of various genes. Levels of expression were normalised to the 
house keeping gene for GAPDH.214'216 The house keeping gene P-actin could not be 
used in this case as its levels change depending on the SMC phenotype.
There are a number of limitations of using this technique to analyse cells that have 
been cultured on specific surfaces. It is impossible to know at what point after cell 
seeding any alteration in gene expression will occur at and how long it will last. The 
surface will alter gradually as the cells secrete their own matrix and so it is likely that 
gene expression will change at the same time. A large number of time points would 
have to be investigated to obtain more accurate results. This would push the number 
of samples to be processed to an impractical level. Due to the extensive processing 
required to synthesise the cDNA the number of sample repeats needs to be kept 
relatively low. This causes large standard deviation values. As can be seen in figures 
36-41 (Images A) some of these values are higher than the mean and therefore cannot 
be plotted on the log scale. This illustrates the unreliability of the data and should be 
taken into account when inferring conclusions from the results. The short time 
periods investigated in this study were chosen as in the first few hours of culture any 
effect of the modified surfaces is more likely to be seen. At longer time points the 
cells will have started to produce their own matrix and so the effects of these proteins 
will also have an effect on the gene expression.
The expression of laminin mRNA by cells cultured on the plain polyurethane, 
fibrillin and tropoelastin-modified surfaces was compared to that of cells cultured on
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glass (Figure 36, Image A). The cells on the plain polyurethane expressed a similar 
level to those on glass at 3 hrs but this increased at 6 and then 24 hrs. This may be 
due to an increase in protein adsorption from the culture medium allowing the cells to 
adhere to the surface more strongly. This in turn may induce the intracellular 
signalling pathways required for protein production. The serum proteins are likely to 
have adsorbed to the glass and polyurethane in slightly different conformations due to 
the different surface properties. It is therefore possible that the cells attached more 
strongly to the polyurethane compared to the glass. This may account for the 
difference in laminin gene expression. However, it can be seen in Figure 36, image C 
that the standard deviation of the data at 6 and 24 hrs is very high and this should be 
taken into account when drawing conclusions.
On the fibrillin-modified surface cells expressed slightly more laminin mRNA than 
those cultured on glass at all time points. Again, image C in Figure 36 shows a large 
standard deviation of the data at 24 hrs and at 3 and 6 hrs it was higher than the mean 
value and so could not be plotted on the graph. This conclusion is therefore 
unreliable. Laminin gene expression by cells cultured on the fibrillin surface was also 
compared to that by cells on the plain polyurethane (Figure 36, Image B). mRNA 
levels decreased on the fibrillin compared to the polyurethane over the 24 hrs. This is 
caused by a rise in expression on the polyurethane with little change on the fibrillin. 
However, due to the large standard deviation demonstrated in Figure 36, image C, 
this trend is unlikely to be accurate.
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The expression of laminin mRNA by cells cultured on the tropoelastin-modified 
surface varied considerably with a higher level than on glass and plain polyurethane 
at 3 and 24 hrs but a lower level at 6 hrs (Figure 36, Images A and B). This may be 
due to the changing surface as the cells secrete their own matrix. It is also possible 
however that experimental error could be the cause and further repeats of the 
experiment would elucidate this. In this case repeats were not possible due to 
availability of samples.
The gene expression for elastin showed a similar trend to laminin (Figure 37). Cells 
on the plain polyurethane surface expressed gradually more mRNA over the 24 hrs. 
Again this may be due to increasing amounts of adsorbed protein and also variations 
in the conformation.
On the fibrillin-modified surface, elastin expression decreased over the 24 hr time 
period. By noting the scales of these graphs (Figure 37) it can be seen that the 
changes were extremely low and combining this information with the large standard 
deviation of the data in image C means that any difference to the glass or 
polyurethane surface is unlikely to be significant.
Elastin gene expression by cells on the tropoelastin-modified surface was higher than 
on glass and polyurethane at 3 and 24 hrs but lower at 6 hrs. These differences could 
be due to the constantly changing surface as the cells adhere and secrete proteins. The 
scales of the graphs demonstrate that these differences were fairly small and so the
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observed changes may be due to experimental error caused by the large number of 
steps needed to prepare the cDNA and the subsequent processing for the PCR.
The levels of fibrillin-1 mRNA appear to be a lot lower on all of the surfaces 
compared to glass and polyurethane at 3 hrs (Figure 38, Images A and B). Again, the 
scale of the graphs shows that the differences are in fact extremely small. On plain 
polyurethane the expression at 6 hrs was similar to glass and by 24 hrs it was almost 
identical. This was the same for cells cultured on the fibrillin-modified surface. On 
the tropoelastin surface the cells expressed more fibrillin-1 mRNA than on glass at 6 
hrs but this decreased to a level similar to it at 24 hrs. Expression was almost 
identical to glass and polyurethane on the modified surfaces at 24 hrs indicating that 
the type of surface had very little effect on fibrillin-1 gene expression.
As a general indicator of protein synthesis the levels of fibronectin mRNA were 
measured. SMCs with a more contractile phenotype produce very little extracellular 
matrix whereas synthetic SMCs produce a lot more. The level of fibronectin synthesis 
can therefore be a guide to the phenotype of the cells cultured on the different 
surfaces. Figure 39, image C shows the levels of fibronectin mRNA produced by the 
cells. The large standard deviation shows that this data is highly unreliable. In a 
number of cases it was so high that it could not be plotted on the graph. For this 
reason any conclusions drawn from the data would be meaningless. Further repeats of 
the experiment would need to be carried out to obtain more accurate data.
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Smooth muscle a-actin (SMA) is the main type of actin found in SMCs. Its levels are 
decreased as the cell phenotype changes from a contractile to synthetic. Compared to 
cells on the glass surface the expression of SMA mRNA by cells on the plain 
polyurethane was similar at 3 hrs but slightly higher at 6 and 24 hrs (Figure 40, Image 
A). The variation at the 6 and 24 hr time points may be due to differences in serum 
protein conformation once adsorption on to the two surfaces had occurred. This may 
have caused a variation in the strength of cell attachment or in the cell adhesion 
molecules involved. Both of these differences have the potential to alter signalling 
pathways within the cells and therefore change gene expression.
Cells cultured on the fibrillin surface expressed considerably more SMA mRNA at 3 
hrs than on glass or polyurethane (Figure 40, Images A and B). In theory this would 
correspond to the cells having a more contractile phenotype on the modified surface. 
However, this result is contradictory to those shown in figures 28, 30 and 32. These 
results strongly indicate that at 3 hrs on the fibrillin-modified surface the cells have a 
more synthetic phenotype rather than a contractile one. This in addition to the huge 
standard deviation of the data suggests that the cells are not in reality contractile and 
the measured gene expression is an inaccurate marker of the SMC phenotype in this 
instance. At 6 and 24 hrs the cells were seen to produce similar amounts of SMA 
mRNA to those cultured on glass (Figure 40, Image A).
At 3 hrs cells cultured on the tropoelastin-modified surface produced an extremely 
high level of SMA mRNA compared to those on the glass and polyurethane (Figure 
40, Images A and B). Again, this is theoretically representative of a more contractile
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phenotype. The images and data shown in figures 29, 31 and 33 indicate that at 3 hrs 
the cells had a fairly synthetic phenotype. Figure 40, image C shows high standard 
deviations in the PCR data and so the contrasting data from the other experiments is a 
more reliable indicator of the phenotype of SMCs cultured on the tropoelastin surface 
at 3 hrs. At 6 hrs the expression of the SMA gene decreases dramatically from that at 
3 hrs. The level of mRNA is similar to that produced by cells cultured on glass and 
slightly less than that produced by cells on the plain polyurethane. This low level of 
gene expression correlates with the evidence of synthetic SMCs from other 
experiments.
Smoothelin is a specific marker of the contractile SMC phenotype. The expression of 
the gene by cells cultured on the plain polyurethane can be seen to increase over the 
24 hrs (Figure 41, Image C). This suggests that the cells were becoming more 
contractile over this time period. Results from other experiments however contradict 
this conclusion (Figures 28-33). These experiments indicate a highly synthetic 
phenotype of SMCs cultured on the polyurethane. Figure 41, image A shows that 
levels of smoothelin mRNA production were also higher in cells on polyurethane 
compared to those on glass. Due to the small scale of the graphs these differences are 
very small and so unlikely to be significant.
Compared to glass and plain polyurethane cells cultured on the fibrillin-modified 
surface produced slightly more smoothelin mRNA at 3 and 6 hrs but less at 24 hrs. 
Again, the scale of the graphs show that these differences are small and so any 
conclusions drawn would be unreliable. The low level of smoothelin mRNA
138
production is expected as other experiments indicate that the SMCs have a synthetic 
phenotype when cultured on the fibrillin surface.
Levels of smoothelin gene expression by cells cultured on the tropoelastin-modified 
surface varied considerably over the 24 hr time period. Compared to cells on the plain 
polyurethane SMCs on the tropoelastin produced gradually less smoothelin mRNA. 
This is due to an increase in gene expression by cells on the polyurethane in 
conjunction with little change in expression by cells on the protein. High standard 
deviations of this data mean that accurate conclusions are not possible.
4.7 -  Immunostaining
4.7.1 -  Cell-matrix Adhesions
Three general categories of cell-matrix adhesions have been identified.217 Classical 
focal adhesions are located at the cell periphery and are associated with actin stress 
fibres. These are rich in vinculin and paxillin and the integrin av(33. Fibrillar adhesions 
are elongated/beaded structures and are located more centrally in the cell. These 
contain high levels of tensin and the integrin a5Pi. The last category is mosaic 
adhesions, which contain a combination of the proteins. Previous research involving 
cell adhesion to fibronectin-modified surfaces has shown that the type of adhesion 
varies with the deformability of the protein.41’218 Cells were seen to attach via 
classical focal contacts when the fibronectin was covalently immobilised whereas 
fibrillar adhesions were the method by which cells attached to adsorbed protein. The
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immobilisation of the fibronectin causes a high level of tension along the 
cytoskeleton followed by the formation of large focal contacts. When the fibronectin 
is deformable there is less tension and this allows for translocation of the adhesions 
and the tension-independent recruitment of tensin and integrin (X5P1 resulting in the 
formation of fibrillar adhesions.
In section 3.3.1.2 it was shown that the integrins CI5P1 and avP3 were involved in SMC 
attachment to the fibrillin-modified surface. To investigate the mechanism of cell 
attachment further, cells were probed with antibodies to these integrins.
Image C in Figure 43 shows the result of staining cells that have been cultured on a 
fibrillin-modified surface for the integrin sub-unit as. There is definite positive 
staining indicating the presence of this sub-unit at the cell surface. More importantly 
it can be seen that the staining shows specific structures. The brightest areas are close 
to the nucleus of the cells. This might indicate the presence of fibrillar adhesions as 
these are known to contain a high concentration of the asPi integrin. This theory is 
backed up by image C in Figure 44. This shows the cells cultured on the fibrillin 
surface but this time stained for the Pi sub-unit. Again fluorescence is brightest near 
to the nucleus indicating the presence of fibrillar adhesions. Another point of interest 
is the presence of elongated structures in the nuclear regions of the cells stained for 
both the 05 and Pi sub-units. These are especially clear in for the Pi sub-unit where 
the structures extend out from the nucleus towards the edge of the cells. The presence 
of organised structures rather than diffuse staining shows that the a5Pi integrin is 
directly involved in the mechanism of cell adhesion to the fibrillin-modified surface
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after 2 days. The presence of fibrillar adhesions could be further investigated by 
staining the cells for the protein tensin. This is found in fibrillar but not classical focal 
adhesions.
It has been said previously that fibrillar adhesions have been shown to form when 
cells are cultured on adsorbed fibronectin but not when it is covalently attached. It is 
a necessary requirement for fibrillar adhesions that the surface that the cells attach to 
is deformable. This is because fibrillar adhesion formation requires the translocation 
of integrins. Soon after cell seeding focal contacts form, these contain both the (X5P1 
and avp3 integrins. After a length of time, if the protein surface is deformable, the
219<X5pi integrin translocates towards the centre of the cell forming fibrillar adhesions. 
Although these published results relate to fibronectin-modified surfaces it is likely 
that parallels can be drawn with the fibrillin-1 surfaces investigated here. With this in 
mind it would be expected that focal adhesions would be the main type of cell-matrix 
adhesion as the fibrillin is covalently attached rather than adsorbed. In fact it appears 
that fibrillar adhesions are a major source of attachment. This can be explained by the 
differences in the methods of covalently attaching the proteins. In this work the 
fibrillin is attached via a layer of dextran. From the results in section 3.2.2 it was 
deduced that the dextran was attached to the polymer surface at a small number of 
points. This allowed for random movement of the polysaccharide and was the reason 
for its ability to prevent protein adsorption. It is therefore possible that the covalent 
attachment method enables significant movement of the fibrillin and so fibrillar 
adhesions are able to form.
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Cells were also stained for the integrin avp3 (Figure 45). Cells cultured on the 
fibrillin-modified surface showed diffuse staining and few definite structures apart 
from some bright areas along the periphery of the cells. It appears that the a vp3 
integrin is involved in SMC attachment to the modified surface but to less of an 
extent than the a5pi integrin. These results are backed up by the results of the integrin 
blocking studies shown in section 3.3.1.2. The graphs in Figure 26 show the 
involvement of both integrins but it is clear that blocking the asPi integrin has a much 
greater effect than blocking the a vp3.
Along with the avp3 integrin, the protein vinculin is highly concentrated in classical 
focal contacts. In order to elucidate whether or not this type of cell-matrix adhesion 
was present along with the fibrillar adhesions the cells were stained for vinculin 
(Figure 46). Cells on the fibrillin-modified surface showed no signs of any positive 
staining for vinculin. Positive staining would appear as short, bright lines at the edges 
of the cells. In this case the fluorescence was diffuse indicating that there were no 
vinculin-containing focal contacts present at this 2 day time point. These results point 
to fibrillar adhesions as the main way that these SMCs attach to the fibrillin-modified 
surface. It is possible that at shorter time points however that this might not be the 
case. If the cells were stained before translocation of the matrix adhesions had 
occurred then classical focal contacts may have been visible. Another reason for the 
lack of vinculin-containing adhesions could be that due to the synthetic phenotype of 
the cells the protein is down-regulated. As mentioned in section 1.2.4, during 
modulation of SMCs from a contractile to a synthetic phenotype, meta-vinculin levels 
increase whilst vinculin levels decrease.181 Probing for meta-vinculin would elucidate
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this. One published study has suggested that the majority of adhesion strength is due 
to integrin clustering with a smaller contribution from focal contact formation.220 This 
would explain why the cells appear to be well attached and spread but there is no 
positive staining for the classical focal contact proteins.
In section 3.3.2 it was shown that the avP3 integrin was involved in mediating cell 
attachment to the tropoelastin-modified surface in agreement with previous work 
carried out on adsorbed protein. The involvement of the asPi integrin was not 
investigated at this time due to the limited availability of the tropoelastin protein and 
the large number of samples necessary for the experiments. No previous research has 
been published that looks at whether or not this integrin binds to tropoelastin. As the 
immunostaining procedure requires relatively few samples, the tropoelastin surfaces 
were included in the experiments. More noteworthy conclusions about the method of 
cell attachment to the tropoelastin surface could be drawn if the integrin blocking 
studies involving the (X5P1 integrin were carried out.
Figure 43 shows positive staining for the as sub-unit in and around the nucleus of the 
SMCs cultured on the tropoelastin-modified surface. There is also bright staining 
around the periphery of the cells and along the extensive filipodia that extend out 
from them. The presence of these structures and the lack of diffuse staining indicate 
that the as sub-unit is involved in cell attachment to this surface. The Pi sub-unit was 
also stained (Figure 44). The fluorescence is specific to elongated structures that are 
present in and extend out from the nucleus. These features are highly organised show 
that the Pi sub-unit is also involved in the method of cell attachment. The bright
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staining at the nucleus and the highly specific staining of the as and pi sub-units 
suggest that fibrillar adhesions are a major type of cell-matrix adhesions on the 
tropoelastin surface. Further staining for tensin would elucidate this further.
The SMCs cultured on the tropoelastin-modified surface also stained positive for the 
avp3 integrin. Image D in Figure 45 shows lots of filipodia extending out from the cell 
body across the protein surface. These results show that the avP3 integrin is involved 
in mediating SMC attachment to the tropoelastin-modified surface and this is backed 
up by the integrin blocking study in section 3.3.2. The filipodia are visible when 
stained for both the a5Pi and avP3 integrins. This indicates that they are co-localised 
and so points to mosaic adhesions as being important in the attachment of the cells to 
the surface.
As with the cells cultured on the fibrillin surface, there was no positive vinculin 
staining on the tropoelastin (Figure 46). This is further evidence that there is a lack of 
strong, classical focal adhesion formation.
Staining of cells cultured on glass and plain polyurethane also shows a high level of 
fluorescence indicating the presence of the a5Pi integrin. Staining for the as sub-unit 
is more diffuse than for the Pi. There are fewer definite structures. The images in 
Figure 43 and Figure 44 show that the staining is similar on the glass and fibrillin 
surfaces. Cells on the polyurethane have very little Pi staining indicating that the 
attachment of the cells is less efficient. It is clear that the asPi integrin is involved in 
the attachment of cells to both the glass and polyurethane surfaces or more correctly
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to the serum proteins adsorbed onto these surfaces. This is expected as there is a lot of 
research that shows that cell attachment to fibronectin, one of the major serum 
proteins, is mediated partially by this integrin.
Cells cultured on the glass discs stained positive for the avP3 integrin. It can be seen 
in Figure 45, image A that there are features at the edge of the pictured cell that 
resemble classical focal contacts. However, it would be expected that these would 
also be visible when stained for vinculin. It is clear from Figure 46 that this is not the 
case. As with the cells cultured on the other surfaces the fluorescence is diffuse and 
no definite structures are visible.
Figure 45, image B shows a cell with a small number of short filipodia stained by the 
anti- avP3 integrin. This shows that this integrin does mediate cell attachment to the 
serum proteins adsorbed onto the polyurethane surface but that the attachment does 
not appear to be strong.
Neither the cells cultured on the glass nor the polyurethane surface showed any 
positive staining for vinculin. This could either be due to a lack of strong classical 
focal contacts or to low levels of the protein due to the synthetic phenotype of the 
cells.
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4.7.2 -  Extracellular Matrix Proteins
Laminin is one of the major proteins that make up the basement membrane of SMCs. 
The basement membrane is especially important for this cell type as it helps regulate 
the phenotype of the cell.1,4’136’177’221 In vivo, disruptions of the membrane and 
subsequent exposure to other ECM proteins such as fibronectin are thought to trigger 
the transformation of SMCs from a contractile to a synthetic phenotype. The cells 
then proliferate and contribute to the narrowing of the blood vessel. SMCs were 
cultured on glass, plain polyurethane and the 2 modified surfaces. They were stained 
for laminin after 2 and 4 days in culture (Figure 47). There is positive staining on all 
of the surfaces at both time points. The laminin has a mottled appearance throughout 
the cell cytoplasm. At 2 days there are significant amounts of the protein in the cells 
cultured on the glass and modified. At 4 days there is no increase in the amount of 
laminin in the cells on these surfaces but it is clear that the cells have proliferated. 
This suggests that the rate of laminin production restricts the build up of the protein 
in the cytoplasm. This is backed up by observing the cells cultured on the plain 
polyurethane. There is more laminin evident in the cells at 4 days than 2 days. The 
lack of cell proliferation has enabled a build up of protein to occur. The PCR data 
presented in section 3.7 (Figure 38) shows an up-regulation of the laminin gene at the 
24 hr time point. Although there are large errors associated with the PCR data, as 
mentioned previously, these 2 sets of results are consistent.
Collagen type IV is another major protein of the basement membrane. Positive 
staining for this protein was evident in the cells cultured on all of the surfaces at both 
2 and 4 days (Figure 48). The collagen has a speckled appearance and is visible in
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significant amounts throughout the cytoplasm of the cells cultured on the glass and 
modified surfaces. As with the laminin staining is brighter on the polyurethane after 4 
days due to a lack of cell proliferation.
It is clear that the SMCs are actively synthesising these 2 basement membrane 
proteins when cultured on either of the protein-modified surfaces. The rate of 
synthesis of both laminin and collagen IV is a lot lower for the cells on the plain 
polyurethane. Both the fibrillin and the tropoelastin can be said to encourage the 
production of basement membrane proteins but to no greater extent than the glass. It 
is probably more accurate to say that the plain polyurethane discourages the protein 
synthesis. This is likely to be due to the poor cell attachment.
Immunostaining was also used to investigate synthesis of the proteins that make up 
the elastic fibres of the artery wall. Fibulin-5, tropoelastin and fibrillin-1 were all 
examined. Images of cells stained for fibulin-5 are shown in Figure 49. At the 2 day 
time point bright staining can be seen around the periphery of the cells cultured on 
glass and the two modified surfaces. Fluorescence coming from the cells on the plain 
polyurethane is diffuse and can be attributed to non-specific staining. After 4 days 
fibulin-5 staining can be seen in the cells on all of the surfaces including the plain 
polyurethane. The amount of fibulin-5 has increased most significantly in the cells 
cultured on the two modified surfaces especially the tropoelastin. On this surface 
there is stained protein throughout the cytoplasm with even brighter areas around the 
cell nuclei. This increase in brightness suggests that the rate of fibulin-5 synthesis
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was high enough compared to the rate of proliferation to allow a build up of protein 
to occur.
The results of staining for tropoelastin production can be seen in Figure 50. It was not 
possible to investigate the effect of the tropoelastin-modified polyurethane as the 
antibody would bind to both the recombinant protein and any that was newly 
synthesised by the cells. There is positive staining of the cells cultured on all of the 
other surfaces at the 2 day time point. This is brightest around the cell nuclei. After 4 
days the tropoelastin is evident throughout the cells. There is significantly more 
protein visible in the cytoplasm of the cells cultured on glass than on the fibrillin. The 
proliferation rate of the cells on these 2 surfaces appears to be the same and so it can 
be said that the glass surface has caused an increase in the production of tropoelastin. 
The proliferation rate of the SMCs on the plain polyurethane is a lot lower which 
accounts for the accumulation of protein in these cells.
Cells were also stained for fibrillin-1 however no images were taken. The staining 
was diffuse throughout the cells on all surfaces. It is unclear whether this was due to a 
lack of fibrillin-1 or to incorrect antibody concentrations as optimisation of the 
antibody was unsuccessful. This may have been due to the efficacy of the antibody or 
the absence of any protein on control samples. The RT-PCR data in Figure 36 shows 
an extreme down-regulation of the fibrillin-1 gene and so this would suggest that 
there is a negligible amount of this protein being produced.
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At these time points it appears that the modified surfaces are not directing the SMCs 
to increase their production of these elastic fibre proteins compared to the glass 
control. The cells can be seen to be synthesising fibulin-5 and tropoelastin but no 
fibrillin-1 is evident. As fibrillin microfibrils form the template for tropoelastin 
deposition during elastic fibre formation it is highly unlikely that any fibres will be 
produced. Any of these proteins secreted by the SMCs will remain un-organised. It is 
possible that at longer time points the cells may start to produce fibrillin-1 and there 
may be a degree of fibre formation.
4.7.3 -  Phenotypic Markers
Smooth muscle a-actin (SMA) is the major actin isoform of mature, fully 
differentiated SMCs.172 It is an important constituent of the cell's contractile 
apparatus. The assembly of actin filaments is essential for cellular contraction. During 
foetal development the amount of a-actin increases, with a corresponding decrease in 
P-actin, and the SMCs acquire the ability to contract. In the event of modulation to 
the synthetic phenotype, either due to arterial injury in vivo or culture conditions in 
vitro, the amount of a-actin decreases.
Images A and B in Figure 51 show SMCs cultured on glass discs for 4 days. Well- 
organised actin filaments can be seen in the cells. At this 4 day time point the cells 
are almost confluent. The cells pictured in image A are in fact growing on top of 
other cells. There are 2 cells visible in image B. One is growing on the glass and the 
other is growing on top of other cells. There are no organised actin fibres visible in
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the cells that are in direct contact with the glass only in those that are growing on top 
of other cells. The same phenomenon is true of the cells cultured on the plain and 
modified polyurethane surfaces (images C-E). No actin fibres are visible in any of the 
cells in direct contact with the surface, just a degree of diffuse staining. This could be 
due to a lack of sufficiently strong cell-matrix adhesions. As was discussed in section 
4 .9 .1, there is no evidence of strong focal contact formation in the cells cultured on 
these surfaces. These are necessary for the assembly of actin stress fibres. As 
mentioned previously, the cells cultured on the modified surfaces have many of the 
characteristics of a synthetic phenotype rather than a contractile one. A low level of 
SMA is another of these characteristics and so it is not surprising that these cells are 
displaying a low level of positive staining for the protein. This lack of a-actin fibres is
178also seen when SMCs are cultured on a fibronectin substrate.
Other phenotypic markers of SMCs include smoothelin, calponin and caldesmon. 
Smoothelin is associates with the actin cytoskeleton and is only present in contractile 
SMCs. It is therefore not surprising that the cells cultured on all of the surfaces 
stained negative for this protein (Figure 52). All of the results obtained during this 
work point to the cultured cells having a synthetic phenotype. Calponin and 
caldesmon are also associated with the contractile apparatus of SMCs. They are both 
up-regulated in cells of the contractile phenotype and only found in very low amounts 
in synthetic cells. As expected, the cells cultured on the plain and modified surfaces 
all stained negative for these proteins.
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4.8 -  Western Blot Analysis
Protein was harvested from cells cultured on glass, and plain and modified 
polyurethane for 2 and 4 days. Western blot analysis was then used to assess the 
amount of different proteins present in each sample. Images were obtained by 
chemiluminescent detection. They were then inverted and the contrast and brightness 
altered to obtain the clearest pictures. Figure 53 shows the images of the gels that 
were probed with antibodies for the GAPDH control and for smooth muscle a-actin. 
Bands are visible on all 4 surfaces at both time points on the GAPDH gels (images A 
and C). The size of these bands represents the amount of cells present on each 
sample. The amount of the other proteins is then normalised to this to eliminate 
variations in protein concentration due to different cell numbers. The size of the 
bands agree with both the qualitative results shown in Figure 28 and Figure 29 the 
quantitative results shown in Figure 32 and Figure 34. There are more cells on the 
glass and modified surfaces than on the plain polyurethane. There are also fewer cells 
on the tropoelastin than on the fibrillin surface. The bands can be seen to increase in 
size from 2 to 4 days as a result of the cell proliferation.
Images B and D in Figure 53 show gels stained with an antibody for smooth muscle 
a-actin. At 2 days there is nothing visible on the gel but after 4 days there are very 
slight bands in the fibrillin lanes. It is likely that the concentration of protein from 
most of the samples is too low to be detected. Bands can only be seen from the 
samples where the cell number is highest i.e. on the fibrillin-modified surface. Due to
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the bands being so faint it was not possible to quantify the amount of protein using 
the Genenome software.
Gels were also probed with antibodies for laminin, collagen IV, fibrillin-1, 
tropoelastin, smoothelin, calponin and caldesmon. No bands were visible on any of 
these gels. From the results of the immunostaining experiments it might be expected 
that there would be some evidence of laminin, collagen IV and tropoelastin. It is 
likely that the level of these proteins was too low to be detected by this method. 
Larger samples would be needed to get a cell number high enough to get a protein 
concentration that could be detected.
4.9 - General Discussion and Further Work
The results presented in section 3.1 show that the surface modification previously 
used to attach peptides to the polyurethane Tecoflex can also be used, in an adapted 
form, to covalently attach proteins to the polyurethane b9 Z1A1.187 In this work 2 
different proteins were immobilised using this method. This indicates that other 
proteins could be successfully attached in this way. By using the dextran intermediate 
the cellular response to the modified surfaces could be attributed solely to the 
covalently immobilised protein.
The modification of the surface of flat films of polymer was investigated here. To use 
this method in the context of the hybrid artery the protocol would have to be
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transferred to a porous scaffold. It has previously been shown that the aminating step 
of the modification does not disrupt the fibrous structure of an electrospun 
scaffold.187 This is encouraging as it might be thought that the DMAc would dissolve 
the fibre surface to the extent that the porous structure would be lost. It should 
therefore be possible to use this protocol to immobilise proteins on an electrospun 
porous scaffold such as that necessary for the production of an artificial artery. This 
would need to be investigated by carrying out the modification and using ELISAs to 
determine its efficacy.
The attachment of SMCs to both proteins was found to be, at least in part, mediated 
by integrins. This was determined by integrin blocking studies and immunostaining. 
Blocking the 0^3 integrin with antibodies resulted in reduced cell attachment to the 
fibrillin fragment. Fluorescent staining of the same integrin showed bright areas 
around the periphery of the cells indicating a degree of clustering. Together these 
results show that there is a contribution from the avP3 integrin in mediating cell 
attachment to the fibrillin-modified surface. Both the integrin blocking and 
immunostaining show that there is a more significant contribution from the (X5P1 
integrin. Blocking antibodies caused a large decrease in cell attachment and 
fluorescent staining of both integrin sub-units shows lots of bright, organised 
structures indicating significant integrin clustering.
Cell attachment to the tropoelastin-modified surface was also seen to be mediated by 
the avp3 integrin. Antibody blocking caused a small but significant reduction in cell 
attachment. The immunostaining shows clear filipodia extending out from the body
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of the cells, providing further evidence of the involvement of this integrin. No 
involvement of the a5Pi integrin in attachment to tropoelastin has been reported in the 
literature. Due to the limited supply of the protein and the large number of samples 
needed for the integrin blocking experiments, this study could not be carried out in 
this project. However, as a much smaller number of samples are needed for 
immunostaining, this experiment was carried out. Staining of the CI5 sub-unit 
especially showed very bright structures around the periphery of the cells and also 
filipodia extending out from them. Staining for the Pi sub-unit showed aligned, 
elongated structures within the cells. Together these images indicate that the a5Pi 
integrin in addition to the avP3 is involved in cell attachment to tropoelastin. Carrying 
out the corresponding integrin blocking studies would elucidate this further.
In previous work, an area of tropoelastin containing the peptide sequence VGVAPG 
was shown to mediate cell attachment via a non-integrin cell-surface receptor termed 
the elastin binding protein (EBP). This is a 67kDa receptor that can be blocked in a 
similar manner to the integrins but by using galactose-based sugars rather than an 
antibody.170,222'224 This method has been used to show the significant involvement of 
the EBP in mediating cell attachment to adsorbed tropoelastin. The presence of the 
VGVAPG sequence on the surface of the covalently immobilised tropoelastin could 
be determined by using soluble peptides or a sugar to block the EBP prior to seeding 
the cells onto the modified surface. If cell attachment was not reduced by the addition 
of the sugar then that would indicate that the modification protocol had altered the 
protein conformation and caused the VGVAPG cell-binding sequence to become 
concealed.
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The integrin blocking and immunostaining studies have elucidated the involvement of 
certain integrins in the attachment of SMCs to the protein-modified surfaces. It is 
known that the binding of different integrins to ligands triggers different intracellular 
signalling pathways. This project did not investigate specific relationships between 
the integrins involved and the aspects of the cells' behaviour, although the previously 
reported link between RGD and the synthetic phenotype of SMCs was seen. In 
order to do this the different integrins would be blocked as before prior to seeding of 
the cell on to the modified surfaces. Various aspects of the cell behaviour would be 
monitored and then compared to that of cells with all integrins available for binding. 
This would give a degree of understanding as to which integrins were associated with 
each particular cellular activity, proliferation for example.
The SMCs behaved differently on each of the surfaces. The fibrillin fragment 
dramatically increased cell adhesion compared to the plain polyurethane. Soon after 
seeding the cells attached and spread out, adopting a fibroblast-like morphology 
characteristic of SMCs in the synthetic phenotype. The cells then proliferated 
extensively on the surface, again indicating that they were more synthetic. 
Immunostaining showed that the cells were actively producing extracellular matrix 
proteins such as laminin and fibulin-5. As SMCs in the contractile phenotype 
synthesise very little matrix these results are further evidence that the cells are
synthetic. This is backed up by the lack of proteins such as vinculin and calponin.
180These have been demonstrated to be down-regulated in synthetic SMCs.
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It is clear from the results that the fibrillin fragment encourages the SMCs to adopt 
the synthetic phenotype rather than the contractile state that they possess in vivo. The 
ability of the cells to proliferate is necessary for the production of the vascular graft. 
A confluent layer of SMCs on the internal surface of the polymer scaffold is required 
for the endothelial cells to grow on top of. A problem would occur however if the 
cells continued to proliferate after a confluent layer had formed. This may cause the 
graft to become blocked. Carrying out cell culture studies for longer time periods than 
were used in this work would give more information as to how the cells would 
behave once they were confluent. It is possible that the cell-cell contact would 
prevent over proliferation. It is also possible that if the cells continued to produce 
extracellular matrix then they may form an environment mimicking that of the native 
artery wall. This may cause the cells to transform into a more contractile phenotype 
and so cease proliferating. Again, studies using longer cell culture periods would 
elucidate this further. The formed extracellular matrix could be imaged using 
immunofluorescence to determine the extent of matrix re-modelling. It would be 
interesting to establish whether there was any elastic fibre formation.
If it was found that at longer time points the cells do not stop proliferating on their 
own then it may be possible to intervene and stop the growth by encouraging the cells 
to revert to a more contractile phenotype. Adding growth factors such as insulin-like 
growth factors I and II to culture medium is a possibility. This has been shown to 
maintain contractile cells in their phenotype.177 Culturing SMCs on an elastomeric 
substrate allows for mechanical stretching of the cells. This has been shown to 
promote a more contractile phenotype.215,225'230 These results are not surprising
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considering the fact that in vivo the cells are constantly undergoing stretching due to 
the pulsatile nature of blood flow through the arteries. By culturing the artificial graft 
in a bioreactor and subjecting the cells to pulsatile stretch after a confluent SMC layer 
has been formed it may be possible to halt cell proliferation and transform the cells to 
a contractile phenotype. Research suggests that stretching also causes alignment of 
SMCs.231'234 This would be an advantage for the artery as the cells would contract in 
the same direction enhancing the physical properties of the scaffold reducing the 
chance of compliance mis-match further. In addition to this if there was any elastic 
fibre formation then the mechanical stretching may also cause their alignment further 
strengthening the artery structure and improving its physical properties.
Cells cultured on the tropoelastin-modified surface had poor initial attachment and 
spreading. There was no improvement compared to the plain polyurethane. The 
addition of SMGS to the culture medium was necessary before the cells adhered 
properly. This may have been due to adsorption of serum proteins to the surface or a 
response to the growth factors now present in the medium. When the cells did adhere, 
they adopted a fibroblast-like morphology as on the fibrillin surface. They then 
proliferated at a similar rate to those on the plain polyurethane surface. 
Immunostaining showed that the cells on the tropoelastin were synthesising matrix 
proteins in similar amounts to the cells on the fibrillin fragment. The morphology of 
the SMCs, in addition to the fact that they were able to proliferate and produce 
extracellular matrix, indicates a synthetic morphology. The lack of cell growth in the 
first 3 hrs of culture is unlikely to be due to the quiescence found in contractile 
SMCs. It is more probable that this is caused by poor attachment to the tropoelastin.
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The cells did not adopt the characteristic bipolar morphology of contractile cells at 
any point.
It was hypothesised that by using proteins native to the artery wall it may be possible 
to control the behaviour of SMCs cultured on the modified surfaces. The cells 
behaved differently on the 2 different protein-modified surfaces. For the purpose of 
the artificial vascular graft the fibrillin-1 fragment has potential as a surface­
modifying agent as it was seen to promote proliferation of the SMCs. This is 
necessary for the formation of a confluent layer on which the endothelial cells would 
be seeded onto. Tropoelastin alone does not appear to be useful as a substrate as it 
neither encourages proliferation nor maintains the SMCs in a non-proliferative 
contractile phenotype.
It is clear that there is a need for carrying out cell culture studies for longer time 
periods in order to establish whether these proteins could be used for modifying the 
internal surface of an artificial vascular graft. It would also be necessary to culture the 
cell-seeded graft in a bioreactor with an applied pulsatile stretch in order to mimic the 
in vivo environment. Further experiments would include the culture of endothelial 
cells on top of the smooth muscle layer.
An implanted vascular graft has to withstand the mechanical stresses caused by the 
pulsatile blood flow immediately following the surgery. In this work a biostable 
polymer has been proposed as its strength and elasticity would prevent rupture of the 
vessel in the time period before significant tissue was established. This enables a
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shorter in vitro culture time to be used and so renders the process more cost-effective. 
This is a vital issue in the development of regenerative medicine products. There are 
however certain problems that occur with long-term implantation of poly(ether 
urethanes). Whilst being hydrolytically stable they can be subject to oxidative 
degradation and stress cracking.235
The majority of tissue engineering strategies focus on using a biodegradable scaffold 
rather than a biostable one as proposed in this work. The scaffold gradually degrades 
in vivo and is replaced by new tissue. This has the advantage that the tissue can be re­
modelled by the cells in response to a changing environment. Bone, for example, 
constantly re-models in vivo in response to changes in stress.
A more favourable situation would be a biodegradable polyurethane with the strength 
and elasticity of the b9 polymer used in this work. The material would be able to 
withstand the in vivo stresses in the period before the formation of adequate new 
tissue. It would then degrade slowly allowing the tissue to re-model.236 The surface 
modification protocol assessed in this project should be able to be transferred to a 
different polyurethane with minimal adaptations.
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Chapter 5 - Conclusions
The aim of this project was to answer 4 main questions.
1 -  Can these proteins be covalently attached to the polyurethane via this 
surface modification protocol?
The results of the surface analysis experiments show that the surface 
modification protocol was successful in covalently attaching both the fibrillin-1 
fragment and the tropoelastin to the polyurethane surface.
2 -  Was the conformation of the proteins adversely affected by the covalent 
attachment process?
It was shown that cell attachment to the fibrillin fragment was RGD- 
dependent and that the integrins a5Pi and a vP3 were involved in mediating the cell 
attachment. These results indicate that both the RGD sequence and a downstream 
synergy site are available for cell binding. These results are similar to those obtained 
by studying the same protein fragment adsorbed onto tissue culture plastic and so it 
appears that the modification protocol does not adversely affect the protein 
conformation.
Cell attachment to the tropoelastin-modified surface was shown to be mediated in 
part by the av(33 integrin. This was in agreement with work carried out on adsorbed
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protein. This indicates that the surface modification protocol does not adversely affect 
the tropoelastin conformation.
3 -  How was the behaviour of the cells affected by the protein-modified 
surfaces?
The cells behaved differently on each of the surfaces. The fibrillin fragment 
increased cell attachment and spreading compared to the plain polyurethane surface. 
In contrast, the tropoelastin showed similar cell behaviour to the plain polyurethane 
surface. These surfaces demonstrated poor cell attachment, spreading and 
proliferation in the absence of serum-containing growth supplement. SMCs cultured 
on both protein-modified surfaces synthesised a number of extracellular matrix 
components.
All of the results point to the SMCs as having a highly synthetic phenotype as 
opposed to the quiescent, contractile phenotype maintained by cells in the artery wall. 
They proliferated, synthesised matrix and displayed no evidence of contractile 
phenotypic markers.
4 -  What are the implications of this research for the development of an 
artificial bypass graft?
The fibrillin-1 fragment has potential for use in the formation of an artificial 
bypass graft. The covalent attachment of this protein encouraged adhesion and 
proliferation of the SMCs. This would be beneficial for covering the polymer surface
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completely with cells. However, in order for this protein to be used, it would need to 
be determined whether the proliferation could be controlled once the cells had 
covered the polymer.
This work investigated two proteins found in blood vessel walls. However, the 
extracellular matrix is a highly complex 3D structure consisting of numerous 
proteins, proteoglycans and polysaccharides. The complexity of the matrix means that 
a truly biomimetic environment would be impossible to achieve using synthetic 
means. For this reason the modification of a surface with a protein is a good starting 
point for gaining some control over cell behaviour.
This adaptability of the modification protocol means that it is not restricted to the 
development of an artificial bypass graft. The majority of tissue engineering and 
regenerative medicine strategies involve the use of a scaffold to support the 3D 
culture of cells. By altering the polymer and/or proteins used, a wide variety of 
applications could be targeted.
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